rfhg_24713.1

Basic information about the TSS

---

TSS ID: rfhg_24713.1 Species: human Chr: chr2		Start: 28751666 End: 28751685 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3103675,EH38E1983901)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000420282.5:0 GeneID: 5500 HGNC/MGI_ID: HGNC:9282 UniProt_ID: C9J9S3 Nearer transcript ids and distances: ENST00000455580.5:-26 ENST00000441461.5:54 AK303682:60 ENST00000427786.1:61 AK295957:61 AK316532:61 NM_206876.2:-62 ENST00000358506.6:63 ENST00000296122.10:129 BX647970:129 AK312329:139 ENST00000395366.3:145 NM_002709.3:145 BX647295:167 X80910:182 ENST00000464273.1:326 BC002697:359 BC012045:359 EU668339:359 AB464241:440 AM392772:440 CR542285:440 BT019744:440 KJ904529:440 CR542263:440 view more...

Gene_name: protein phosphatase 1 catalytic subunit beta Gene_symbol: PPP1CB Gene_synonyms: MP PP-1B PP1B PP1beta PP1c PPP1beta Gene_source: HGNC:9282

TATA-Box annotation

---

Distance to TSS:	-73
Nearest PromoterID:	NM_206876
Entrez ID:	5500
Nearest Unigene:	Hs.702907
Nearest Refseq:	NM_002709
Nearest Ensembl:	ENSG00000213639
Gene Name:	protein phosphatase 1 catalytic subunit beta
Gene Alias:	HEL-S-80p|NSLH2|PP-1B|PP1B|PP1beta|PPP1CD
Gene Type:	protein-coding
CpG%:	0.105263
GC%:	0.650000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p2@PPP1CB p3@PPP1CB p4@PPP1CB p5@PPP1CB p6@PPP1CB p7@PPP1CB p8@PPP1CB p9@PPP1CB
Sample		p2@PPP1CB	p3@PPP1CB	p4@PPP1CB	p5@PPP1CB	p6@PPP1CB	p7@PPP1CB	p8@PPP1CB	p9@PPP1CB
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	7.99	9.16	4.87	4.48	0.97	0.19	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.71	10.52	3.24	3.84	0.61	0.81	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	11.96	10.42	2.70	3.67	0.19	1.16	0.96	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.36	6.86	1.87	2.91	0.42	0.42	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	7.42	6.52	2.02	3.37	0.90	0.90	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.14	9.11	1.74	4.26	0.39	0.97	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	13.51	8.72	6.10	6.75	1.31	0.22	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.20	7.99	3.15	6.78	0.97	0.24	0.48	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.04	4.70	3.85	4.92	0.64	1.28	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	15.07	5.80	6.38	7.54	2.32	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.13	5.66	4.45	6.06	0.40	2.43	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	9.35	4.88	4.88	7.72	1.63	1.63	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.41	17.57	2.26	2.42	0.64	0.16	0.64	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	14.58	14.58	3.01	1.80	0.60	0.00	0.45	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	10.76	17.78	3.29	1.10	0.44	0.44	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.30	12.32	3.02	0.75	0.25	1.01	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.14	13.54	1.09	1.97	1.09	0.22	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	12.65	18.56	1.69	2.53	1.69	1.69	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	9.60	13.86	2.13	2.67	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	14.44	15.35	3.31	1.20	0.15	0.45	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.90	16.97	2.94	1.74	0.80	0.40	0.53	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	11.39	11.74	1.55	1.73	0.69	0.35	0.86	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.96	13.05	2.59	1.42	0.13	0.13	0.26	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.74	11.41	1.94	1.46	0.97	0.97	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	14.71	19.35	1.29	3.35	1.81	0.77	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.66	11.39	1.58	0.63	0.63	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	11.54	21.43	2.20	0.55	0.00	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	17.68	20.98	2.36	1.89	2.83	0.71	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	15.02	14.54	2.10	1.62	1.78	0.32	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	19.36	20.81	4.16	2.17	0.72	0.18	0.36	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	12.77	12.98	2.51	0.84	0.21	1.05	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	10.94	10.75	1.95	2.54	0.20	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.55	16.88	1.69	1.48	0.63	0.84	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.20	19.79	3.79	2.64	1.98	0.99	0.33	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.46	15.71	2.62	1.68	0.56	0.56	0.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	16.48	14.37	3.26	1.72	0.96	0.96	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	14.92	15.94	2.04	2.45	1.02	0.41	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	13.10	17.33	2.01	1.41	0.81	0.60	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.64	14.32	4.05	1.89	0.81	0.54	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	12.96	15.84	1.92	1.68	0.96	0.72	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.47	13.41	2.12	1.88	1.41	0.71	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.25	17.71	2.64	2.49	0.88	0.73	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	13.71	15.82	2.11	1.48	1.90	0.42	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10.66	13.11	3.85	2.10	1.40	0.35	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.85	15.06	3.81	2.41	0.80	0.20	1.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.56	14.66	2.56	2.79	0.47	0.23	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.19	15.35	2.64	2.40	0.72	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	13.11	15.20	1.79	1.49	0.89	0.60	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.57	14.12	2.87	2.87	1.44	0.48	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	11.32	19.01	2.63	2.43	1.01	0.61	0.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.63	17.22	3.28	2.46	1.23	1.02	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.34	19.79	5.11	2.22	1.56	1.56	0.67	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	139.92	13.99	13.99	13.99	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.00	12.77	4.26	3.19	2.13	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	14.58	21.54	2.98	1.33	0.66	1.99	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	27.68	67.11	6.71	5.03	2.52	0.84	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.32	24.34	3.67	2.76	1.38	1.84	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	16.53	22.36	3.24	0.97	0.32	1.30	0.00	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.24	16.38	1.28	0.96	0.00	1.28	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	20.43	26.09	5.03	1.26	1.26	0.94	0.94	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	15.51	12.69	1.41	0.00	1.41	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.58	19.63	2.80	1.68	1.12	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.92	33.44	7.17	0.00	2.39	3.98	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	13.25	20.39	4.76	3.06	1.02	1.36	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.05	14.95	1.95	0.65	0.65	0.65	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.84	17.39	3.55	0.71	0.35	0.35	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	129.31	0.00	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	110.56	165.85	55.28	15.79	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	17.06	0.00	1.46	0.49	0.98	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.42	10.91	1.98	0.99	0.50	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.54	15.01	0.47	1.41	0.94	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	15.90	26.83	1.99	1.66	0.33	0.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.21	19.80	1.86	0.62	0.00	0.31	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.98	18.04	0.92	0.00	0.61	0.31	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	11.88	12.99	3.17	3.01	1.43	0.16	0.79	0.63
Adipocyte - breast, donor2	11327-117E4	12.67	19.41	1.76	1.93	0.80	0.32	0.16	0.32
Adipocyte - omental, donor1	11473-119C6	14.63	30.92	3.44	3.56	2.54	0.76	0.25	0.38
Adipocyte - omental, donor2	11474-119C7	11.21	14.20	2.99	2.24	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	15.41	28.47	3.35	1.67	1.34	0.33	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	23.61	15.95	1.28	1.28	0.64	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	3.30	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	11.74	16.71	1.81	1.35	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.69	8.34	1.39	1.74	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	53.39	34.42	3.52	2.15	1.37	0.78	1.37	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	23.16	30.37	1.54	2.57	1.54	0.77	1.29	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	26.76	30.39	3.35	1.67	1.12	0.56	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	23.51	39.38	3.53	4.11	0.59	0.00	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	52.12	39.81	4.26	2.57	0.72	0.24	0.48	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	24.85	27.11	2.58	1.94	0.65	0.97	1.61	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	19.73	17.60	1.07	0.53	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	20.59	20.03	2.78	3.34	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	25.79	24.54	3.33	0.42	0.42	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	21.10	19.34	3.01	0.75	0.50	0.75	0.50	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	21.60	22.58	2.62	1.96	0.00	0.33	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	23.75	21.31	3.65	2.13	0.91	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	15.69	11.05	1.77	0.66	1.77	0.44	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	4.30	0.36	0.00	0.36	0.00	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	3.59	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	18.35	15.47	2.52	1.80	2.52	0.54	0.18	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	13.39	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.27	10.68	1.23	0.21	0.62	0.21	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	32.27	32.95	5.03	4.12	0.80	0.46	0.69	0.46
Anulus Pulposus Cell, donor2	11463-119B5	38.45	24.49	1.71	2.45	0.98	0.24	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.03	22.02	0.00	0.90	0.45	1.35	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.33	26.48	2.17	0.43	0.00	0.00	0.00	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	19.26	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.13	30.19	1.20	1.20	0.30	0.30	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	24.03	1.26	1.26	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	17.16	2.64	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	16.89	20.79	0.32	0.97	0.97	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.02	27.67	1.46	0.00	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	9.50	19.00	0.00	0.59	0.00	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	14.69	20.72	0.38	0.75	0.38	0.00	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	22.50	23.95	1.45	0.73	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	17.55	0.00	0.00	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	20.26	25.53	2.31	2.31	0.66	0.33	0.49	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	32.76	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.83	22.17	1.51	1.36	0.30	0.00	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.15	21.43	1.61	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.03	22.48	1.32	1.51	0.19	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	12.03	25.12	1.87	0.53	0.53	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	26.34	0.98	0.98	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.58	25.38	1.33	1.16	0.33	0.33	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	21.61	0.00	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	28.32	3.54	0.00	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	16.64	24.19	2.57	1.54	0.34	0.69	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	12.58	0.00	8.39	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	17.48	21.84	0.97	1.46	0.00	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	17.45	26.18	1.14	1.90	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	16.96	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.82	20.52	1.71	1.71	0.57	0.00	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.54	25.23	0.64	1.50	0.43	0.00	0.21	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.61	14.45	1.55	0.26	0.00	0.00	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	12.20	16.42	0.94	0.94	0.47	0.47	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	16.72	23.15	1.93	1.29	0.32	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	19.98	0.71	1.43	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.87	18.13	1.17	2.34	0.00	0.00	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	15.96	18.67	2.11	1.20	0.30	0.30	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	15.44	0.00	3.56	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	15.77	24.41	1.53	2.03	0.00	1.53	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	17.83	24.70	0.76	2.04	0.51	0.25	0.00	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	12.07	1.27	1.91	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	13.81	19.42	1.29	0.86	0.86	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.03	17.15	2.12	0.85	0.42	0.85	0.21	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.57	16.53	1.74	1.16	0.00	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	21.73	17.95	0.94	2.83	0.94	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.27	21.02	3.56	0.34	0.34	0.00	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	18.53	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	25.35	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.79	19.94	1.72	1.50	0.43	1.07	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.03	18.65	1.20	0.60	0.60	0.00	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	11.66	18.95	0.00	0.00	0.00	0.00	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	18.39	25.52	1.15	0.92	0.00	0.23	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	22.95	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	17.29	15.76	2.80	0.76	0.25	0.00	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	18.99	26.01	1.03	2.06	0.00	0.00	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.93	22.03	0.00	0.61	0.31	0.61	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.69	31.07	2.39	1.91	0.48	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	16.41	24.61	2.22	0.67	0.67	0.00	0.22	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	13.73	3.05	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.42	24.37	1.11	2.22	0.55	0.55	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.95	23.04	1.06	0.26	0.79	0.26	0.00	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.45	17.45	0.36	1.09	0.36	0.36	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	23.09	10.81	3.68	3.32	3.68	1.35	1.23	0.49
Astrocyte - cerebellum, donor2	11580-120F5	17.46	7.53	2.74	1.20	0.68	0.51	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	6.71	6.92	0.63	0.00	1.05	0.84	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	72.85	116.43	8.71	4.18	11.85	9.76	4.18	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	56.62	97.55	8.74	5.34	10.03	5.34	1.29	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	70.11	104.11	10.29	6.12	13.72	6.12	2.39	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	48.28	24.43	11.35	10.55	2.06	2.64	2.29	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	52.74	21.80	11.65	10.90	2.13	2.76	2.76	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	48.25	23.21	11.72	9.56	2.05	2.16	2.73	1.14
Basophils, donor1	12241-129G9	12.55	23.54	1.57	4.45	4.71	2.88	0.52	0.52
Basophils, donor2	12242-129H1	31.75	63.14	3.61	6.49	2.53	2.89	1.44	0.72
Basophils, donor3	12243-129H2	35.43	47.63	1.91	4.12	4.70	3.09	1.76	1.32
Bronchial Epithelial Cell, donor1	11511-119G8	15.09	11.00	0.22	0.00	0.43	0.22	0.65	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	6.86	5.03	0.00	0.91	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	43.04	0.00	14.35	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.83	26.36	4.39	0.63	0.00	1.26	1.26	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	14.35	13.10	1.04	1.25	1.46	0.21	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	14.05	11.74	1.84	2.76	0.23	1.38	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	43.73	43.73	2.70	2.16	1.08	0.72	0.90	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	42.66	13.91	6.90	8.55	1.85	1.75	2.68	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	40.29	19.80	8.15	7.69	2.33	1.63	3.96	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	21.42	18.23	5.76	6.72	8.95	4.80	1.28	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	20.68	0.00	10.34	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	43.96	61.99	4.51	7.33	12.96	6.76	0.00	2.25
CD14+ Monocytes, donor2	11305-117B9	28.40	87.42	2.97	2.04	6.87	3.53	1.30	0.56
CD14+ Monocytes, donor3	11381-118B4	33.37	77.06	3.07	2.63	5.71	5.05	1.76	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	52.08	40.76	4.53	4.25	3.11	0.57	2.55	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	45.87	36.39	6.07	2.65	2.27	1.14	0.76	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	71.01	53.26	7.89	4.93	4.27	1.31	1.97	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	37.44	75.89	4.63	3.47	8.09	2.89	1.45	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	31.38	45.86	5.13	6.94	7.54	1.81	1.21	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	35.77	57.33	2.84	3.79	9.95	4.03	1.90	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.30	67.13	1.67	3.35	7.37	3.18	1.51	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	34.78	44.71	3.04	2.21	6.07	3.31	1.38	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	33.47	43.64	4.46	6.69	8.93	2.23	0.99	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	36.22	69.71	3.33	5.09	9.01	2.35	1.17	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	23.32	39.53	3.20	3.20	4.63	2.67	1.07	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	35.04	50.93	4.57	5.01	10.45	3.26	2.39	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	32.08	84.75	3.98	3.75	11.00	1.87	3.75	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	25.87	48.58	4.22	3.17	9.50	3.70	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	33.28	59.91	3.33	5.55	8.87	3.33	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	30.94	69.76	4.16	4.46	9.52	3.57	1.04	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	27.74	40.11	3.59	2.79	5.79	2.59	2.20	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	45.60	73.91	5.83	6.04	9.37	5.83	2.08	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	39.58	107.07	5.95	4.80	10.52	2.75	1.37	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	37.32	60.17	4.07	6.79	9.73	2.94	1.81	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	32.73	68.09	4.36	4.80	11.35	5.67	0.44	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	48.15	63.48	6.46	2.15	8.88	3.23	0.81	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	29.83	39.78	4.36	3.31	7.33	1.92	1.22	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	33.24	49.66	5.89	7.15	8.00	1.68	2.52	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	38.95	80.10	5.14	3.67	10.29	3.86	1.29	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	31.35	53.19	5.28	7.05	8.81	2.82	0.35	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	36.41	59.23	3.95	4.83	9.65	4.83	0.44	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	24.76	61.90	4.88	3.66	7.85	2.62	1.74	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	23.04	41.63	1.86	3.72	6.32	1.49	1.12	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	34.06	45.05	4.31	4.53	8.62	2.80	2.16	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	31.94	61.42	3.69	6.14	8.60	2.46	1.23	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	29.21	51.23	4.64	4.87	7.88	3.48	1.39	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	37.81	66.81	3.94	4.41	12.99	5.80	1.86	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	15.91	20.05	3.49	2.62	4.80	1.74	1.31	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	15.01	29.57	2.31	1.85	8.55	1.62	0.92	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	18.85	20.15	3.68	3.47	6.93	1.30	0.87	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	25.23	21.33	4.36	7.01	7.01	2.02	2.65	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	23.23	26.72	4.72	2.97	5.59	2.27	2.10	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	27.87	33.89	6.91	5.13	10.48	3.34	1.34	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	15.82	24.24	3.06	3.83	7.91	2.55	1.28	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	17.35	34.91	2.63	2.85	6.37	2.20	1.76	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	21.05	26.32	4.21	3.58	6.11	2.32	1.26	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	18.29	2.03	4.06	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	22.37	14.92	2.03	6.10	1.36	0.68	2.71	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	27.96	15.53	4.14	8.28	2.07	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	42.11	20.79	3.20	5.33	2.13	0.53	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	32.16	25.73	4.82	3.75	1.07	2.14	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	26.67	17.55	2.81	4.91	0.70	0.00	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.02	17.26	3.92	5.49	2.35	1.57	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	34.28	18.46	2.64	5.27	1.32	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	21.37	37.81	3.29	5.75	0.82	1.64	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	19.59	41.35	0.73	6.53	1.45	0.73	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	26.76	48.46	4.04	2.02	1.51	2.52	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	123.24	46.87	6.87	2.42	0.40	1.21	0.81	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	86.69	40.75	4.39	4.39	1.20	1.20	1.20	2.40
CD34+ Progenitors, donor1	11545-120B6	13.05	17.07	5.02	8.03	4.02	2.01	4.02	0.00
CD34+ Progenitors, donor2	11625-122B5	28.65	83.15	6.18	11.24	11.80	5.62	1.12	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	31.94	18.41	5.64	6.39	5.64	3.01	5.26	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	24.13	16.01	6.09	7.67	4.96	4.28	4.28	0.00
CD4+ T Cells, donor1	11225-116C1	82.48	89.98	3.93	7.50	1.43	0.71	1.07	0.71
CD4+ T Cells, donor2	11306-117C1	51.44	158.60	1.22	3.06	0.61	0.61	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	55.51	103.39	5.18	7.62	1.52	1.83	2.13	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	28.08	18.63	3.83	3.32	1.53	0.00	1.02	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	29.87	18.42	1.57	2.47	0.22	0.45	0.90	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	23.00	16.10	3.74	3.74	1.44	0.57	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	29.87	25.60	3.32	8.06	0.47	0.47	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	36.52	21.77	4.21	8.43	1.40	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	23.07	0.00	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	25.87	18.93	4.91	5.35	1.73	1.59	0.58	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	19.32	16.27	2.71	1.36	1.19	0.51	1.02	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	14.99	14.83	3.55	1.93	1.45	0.97	0.32	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	24.21	24.21	7.62	4.48	3.14	3.14	3.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.60	27.25	5.24	12.93	1.05	0.00	1.75	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	22.44	21.12	2.20	5.72	0.88	0.88	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	24.88	15.18	4.22	3.79	1.26	0.42	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	25.14	16.62	4.36	3.32	1.66	0.83	0.21	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	20.72	15.04	1.67	3.34	1.67	0.33	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	40.79	23.11	4.08	6.25	1.63	0.00	1.09	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	48.24	28.41	4.82	8.58	0.00	0.54	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	7.17	3.59	16.14	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	28.19	21.51	3.89	5.56	2.97	2.04	1.85	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	22.31	15.81	3.47	2.82	1.52	0.22	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	22.07	16.81	3.57	3.99	1.47	0.84	0.63	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	27.30	32.36	6.57	3.03	1.01	0.00	1.01	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	33.36	29.46	3.47	3.47	0.43	0.00	2.17	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	34.87	30.94	3.92	8.28	0.00	0.87	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	40.08	21.28	7.92	9.40	0.99	1.48	2.47	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	19.39	13.85	8.31	11.08	0.92	1.85	5.54	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	18.15	13.96	6.98	0.00	2.79	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	60.37	29.08	7.75	14.12	2.22	1.11	0.83	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	62.82	28.47	8.34	10.31	1.23	1.96	1.72	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	32.34	18.48	7.70	10.78	6.16	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	40.47	22.56	6.09	8.95	1.79	1.79	0.72	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	66.48	27.70	5.54	9.69	2.77	2.77	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	59.59	66.46	3.27	6.55	0.65	0.33	0.98	0.65
CD8+ T Cells, donor2	11307-117C2	48.43	93.48	2.63	6.01	0.75	1.13	1.13	1.13
CD8+ T Cells, donor3	11383-118B6	60.85	92.16	3.53	7.57	2.02	0.76	0.76	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.57	8.95	1.15	3.21	1.15	0.69	0.46	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.23	8.63	1.68	4.07	1.68	0.24	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	7.66	12.04	1.64	3.28	1.64	0.27	0.82	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	7.81	14.11	2.40	3.60	1.80	0.00	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	7.20	9.84	2.40	2.64	2.16	1.44	0.72	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	7.73	9.78	1.82	2.96	0.91	1.36	0.68	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	7.39	10.21	1.30	2.17	0.22	0.43	0.65	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	6.84	7.11	0.53	1.32	1.32	0.79	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.80	15.24	1.64	2.81	1.88	0.47	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.04	12.68	1.81	4.23	2.42	1.51	0.91	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	7.55	17.72	1.74	2.61	1.74	0.29	0.58	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	11.99	11.99	2.13	4.00	1.07	1.07	0.80	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	7.88	21.01	2.19	3.94	1.31	0.00	2.63	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	7.74	14.12	0.91	3.64	1.82	1.82	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	9.70	18.65	1.49	0.75	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.28	9.72	1.80	4.32	0.36	0.72	1.44	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.91	10.65	2.01	5.18	2.01	0.00	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.07	9.90	2.12	1.89	0.94	0.47	1.18	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	8.56	13.63	1.27	3.17	1.27	1.58	0.95	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	6.77	13.23	2.77	4.00	1.54	0.92	0.92	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	8.98	10.26	0.96	2.89	1.60	1.28	1.92	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.03	13.00	2.29	1.91	3.06	1.53	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	4.34	15.76	0.39	1.18	0.39	1.58	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	15.13	0.76	3.03	1.51	2.27	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	9.64	16.86	0.80	5.62	0.00	3.21	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	14.69	21.68	4.90	4.90	0.00	2.80	2.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	17.03	21.04	5.01	4.01	1.00	3.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	56.66	36.55	0.00	3.66	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	20.26	19.76	1.98	0.49	0.99	0.49	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	40.94	28.83	5.16	2.53	2.10	1.58	0.63	1.05
Chondrocyte - de diff, donor1	11261-116G1	26.69	19.41	2.08	1.73	1.04	0.35	1.04	0.35
Chondrocyte - de diff, donor2	11338-117F6	19.19	7.82	3.55	1.78	0.00	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	19.34	23.21	3.41	2.62	0.91	0.23	0.23	0.46
Chondrocyte - re diff, donor2	11339-117F7	36.71	22.38	8.06	4.48	0.90	0.90	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	28.31	18.20	3.64	2.43	0.81	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	59.44	36.15	10.90	7.46	5.16	3.21	2.18	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	37.62	29.50	5.13	4.70	1.71	0.86	0.64	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	47.70	24.43	7.61	5.31	1.77	2.48	1.06	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	47.13	50.07	7.52	7.15	1.38	1.47	1.28	0.83
Corneal Epithelial Cells, donor1	11526-119I5	11.86	7.03	0.88	0.88	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	5.69	0.00	0.00	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	14.57	10.48	0.26	0.77	0.51	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	29.39	21.13	3.14	1.82	1.32	0.66	0.50	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	33.43	24.29	4.10	1.58	0.95	0.63	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	27.61	0.00	0.00	3.45	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	31.10	19.11	2.27	0.32	0.54	0.97	0.43	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	43.05	42.36	4.78	6.15	1.02	0.34	0.34	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	33.95	37.87	5.22	7.18	0.65	1.31	1.31	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	42.10	43.56	2.42	7.26	0.97	0.00	1.45	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	16.34	16.01	3.34	1.50	1.33	0.67	0.83	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	8.21	8.80	1.76	1.17	0.00	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	11.88	16.12	1.70	2.83	2.26	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	6.29	11.01	0.79	1.57	1.97	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	9.02	10.47	0.58	0.58	0.29	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	13.88	17.18	1.41	1.18	0.24	0.00	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	11.04	14.02	1.75	1.23	0.70	0.53	0.18	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.18	26.82	2.44	0.66	1.77	0.22	0.00	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.99	32.86	3.35	1.52	0.61	0.30	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.60	28.47	3.66	3.66	1.13	0.56	0.85	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	10.40	11.89	0.89	0.89	0.89	0.00	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	10.41	7.29	2.60	3.12	0.52	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	4.96	7.80	0.85	0.00	0.43	0.14	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	38.41	25.61	4.00	3.60	1.20	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	7.34	12.58	1.05	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	42.00	47.21	5.09	6.59	5.84	2.36	1.62	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	27.16	38.67	7.60	3.69	4.56	1.30	0.87	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	30.29	32.61	5.74	5.13	4.64	1.59	1.22	0.49
Endothelial Cells - Vein, donor1	11267-116G7	7.96	10.24	3.41	1.14	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	5.59	13.97	2.10	2.10	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	17.58	22.92	2.51	1.57	0.94	0.63	0.47	0.63
Eosinophils, donor1	12244-129H3	30.49	45.74	0.00	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	178.23	252.49	9.90	19.80	77.56	28.05	11.55	1.65
Eosinophils, donor3	12246-129H5	124.84	267.51	14.27	24.97	67.77	21.40	7.13	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	9.77	6.84	1.22	0.24	0.24	0.98	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	12.48	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	48.81	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	28.33	18.47	3.69	3.69	0.00	0.41	0.82	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.42	11.39	1.53	0.99	0.00	0.22	0.11	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.98	16.25	3.14	1.95	0.43	0.43	1.08	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	30.93	29.59	4.37	3.40	0.97	0.12	0.97	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.11	15.69	4.23	2.46	0.41	0.27	0.27	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	24.47	19.51	2.74	1.69	0.74	0.63	0.63	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	23.45	18.97	1.32	2.63	0.79	0.26	0.53	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	30.23	29.23	3.99	1.33	2.33	1.00	0.00	1.99
Fibroblast - Cardiac, donor1	11268-116G8	20.87	33.57	2.72	0.45	0.91	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	12.13	6.82	0.00	3.03	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.83	12.30	1.42	0.63	0.32	0.16	0.16	0.79
Fibroblast - Cardiac, donor4	11452-119A3	47.28	38.80	6.37	2.73	2.42	0.91	0.91	0.91
Fibroblast - Cardiac, donor5	11456-119A7	33.63	35.28	3.68	2.54	1.27	0.63	0.63	1.02
Fibroblast - Cardiac, donor6	11460-119B2	25.62	24.56	2.43	1.52	2.12	0.30	0.45	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	20.90	8.71	1.47	0.80	1.61	0.40	0.13	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	18.98	31.93	1.73	0.00	1.29	0.43	0.00	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	17.58	7.32	2.93	4.39	0.00	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	14.07	6.00	1.15	2.31	0.23	0.23	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	29.85	33.41	1.87	1.87	0.51	0.51	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	17.61	25.36	2.82	1.17	0.47	0.94	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	6.60	8.02	1.42	0.94	2.36	0.00	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	14.87	18.01	1.09	1.45	0.36	0.24	0.12	0.48
Fibroblast - Dermal, donor4	11450-119A1	27.81	24.64	5.88	3.73	2.49	1.58	0.57	0.34
Fibroblast - Dermal, donor5	11454-119A5	21.63	26.52	3.66	4.88	1.92	1.22	0.70	0.70
Fibroblast - Dermal, donor6	11458-119A9	26.48	29.24	4.55	4.39	2.44	0.65	1.30	0.81
Fibroblast - Gingival, donor1	11237-116D4	27.49	28.32	3.33	3.33	1.25	0.62	0.42	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	17.55	29.08	4.72	2.88	1.57	0.52	0.00	0.79
Fibroblast - Gingival, donor2	11318-117D4	23.46	22.67	2.90	3.16	0.79	0.40	0.92	0.00
Fibroblast - Gingival, donor3	11394-118C8	30.46	34.81	3.67	3.00	0.87	0.29	0.29	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	32.21	7.27	4.16	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	24.14	22.55	4.41	1.76	0.35	0.35	0.35	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	20.89	25.72	4.99	3.74	1.40	0.62	0.62	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	19.61	20.28	3.92	2.16	1.49	0.54	0.27	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	32.82	31.41	3.88	3.88	1.76	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	20.04	22.08	7.02	3.22	2.05	1.02	0.44	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	22.63	32.04	4.50	3.41	1.64	0.55	0.41	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	20.07	32.36	4.50	4.94	1.97	0.88	0.66	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	19.08	22.45	3.08	2.20	0.29	0.29	0.29	0.44
Fibroblast - Lung, donor1	11270-116H1	8.16	5.44	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	26.86	22.38	2.98	4.48	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	13.30	16.88	1.27	1.48	1.06	0.21	0.21	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	5.83	0.00	0.83	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	6.99	0.00	0.00	0.00	0.00	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	0.84	0.28	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	15.02	12.59	2.84	0.81	0.81	0.00	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	7.99	7.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	23.83	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	27.35	23.66	4.66	3.69	3.10	0.58	0.78	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	28.82	34.13	6.83	4.85	2.28	1.06	1.21	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	35.49	28.76	5.20	4.59	3.67	0.61	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.71	19.84	2.29	4.58	1.14	0.38	0.76	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	20.52	15.39	2.16	1.89	0.54	0.00	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	26.33	24.35	4.75	2.67	1.04	0.70	0.81	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	26.97	25.31	2.43	2.43	2.10	0.88	0.55	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13.61	11.18	2.03	0.81	0.20	0.61	0.00	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.01	7.35	2.00	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	21.74	17.40	1.19	1.58	0.40	1.19	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	29.57	20.04	3.57	1.98	1.98	0.79	0.20	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	24.16	20.43	3.73	4.80	1.78	0.71	0.00	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	36.66	21.88	3.35	3.15	0.39	0.59	0.59	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.66	14.14	2.11	3.01	0.90	0.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	48.15	35.08	4.75	3.35	1.08	0.65	0.43	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	38.72	20.25	4.30	2.53	1.52	0.25	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	31.83	13.78	3.61	2.95	0.66	0.49	0.16	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	27.87	16.24	4.41	2.01	1.80	1.20	1.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	44.71	26.92	7.43	4.32	1.61	0.60	1.11	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	44.13	17.83	2.72	2.72	1.81	0.30	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.33	29.82	3.73	2.49	0.75	0.08	0.41	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	45.64	29.75	4.27	3.59	0.17	0.51	0.51	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	27.26	20.03	4.60	0.99	0.33	0.33	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	41.97	31.00	4.15	4.37	1.92	1.17	0.75	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	31.04	16.19	3.54	4.05	1.86	0.51	0.17	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	21.80	20.70	4.23	2.20	0.94	0.47	0.00	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	199.44	288.08	110.80	66.48	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	106.33	106.33	6.97	2.61	6.97	4.36	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	25.48	46.46	2.95	2.25	0.69	0.00	0.35	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	27.85	33.83	5.47	1.56	0.00	0.00	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	21.21	42.42	5.62	3.07	1.79	0.26	1.02	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	40.57	20.67	5.36	4.59	2.30	5.36	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	31.90	27.44	6.38	7.02	0.64	0.64	3.19	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	54.77	30.24	10.27	5.99	2.85	2.28	3.42	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	52.39	32.54	5.24	5.52	1.93	1.65	0.83	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.68	19.18	3.88	4.11	1.83	1.14	2.05	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	40.22	21.79	5.35	5.55	1.39	3.17	1.39	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	53.13	23.26	2.38	4.23	1.85	1.32	1.85	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	35.22	21.85	2.61	4.57	0.98	0.33	0.33	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	47.76	25.21	7.08	7.52	2.65	1.33	3.98	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	42.11	26.71	4.52	6.50	2.26	3.39	1.84	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	34.11	29.18	4.93	4.68	1.97	1.97	3.45	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	44.05	26.86	4.03	6.45	2.15	2.42	1.88	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	36.18	27.13	5.70	4.71	2.23	2.11	2.11	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	47.76	33.36	5.95	5.95	3.74	2.77	2.08	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.34	23.58	3.25	3.66	1.63	3.05	1.22	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	32.17	26.47	3.65	4.11	1.83	2.51	1.37	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	39.86	36.87	3.49	4.11	2.24	2.62	2.12	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	50.27	38.25	4.37	5.25	2.19	3.28	1.97	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	28.37	30.73	3.84	4.43	1.48	2.66	2.07	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	37.83	32.59	3.50	5.09	2.70	2.54	1.91	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	33.07	22.57	4.92	4.47	3.13	2.23	1.79	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	32.06	32.26	2.02	3.83	2.82	2.02	1.21	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	39.02	37.15	5.77	4.07	2.88	2.88	2.21	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	36.44	36.00	3.64	5.76	4.43	3.46	1.86	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	11.55	12.59	3.43	4.58	3.33	1.66	1.66	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.49	11.78	3.76	3.24	3.59	1.02	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	37.62	31.98	5.31	3.10	3.54	1.66	1.33	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.61	28.45	5.32	5.66	3.74	2.25	1.83	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	37.57	25.93	4.49	4.70	3.06	2.04	2.04	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	30.33	26.20	5.36	4.75	1.03	2.06	2.06	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.01	30.67	4.96	4.15	3.11	2.42	1.73	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	30.35	28.35	5.84	2.67	2.50	1.00	1.17	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	25.13	24.47	1.98	2.42	1.54	1.76	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	32.84	31.12	4.18	4.06	2.21	2.21	2.34	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	32.42	21.72	3.08	3.24	3.57	2.92	1.78	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.09	31.11	0.96	2.57	1.92	0.64	0.96	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	35.91	32.22	3.41	3.13	2.84	1.52	1.04	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	25.62	25.62	2.85	3.01	1.58	1.27	2.06	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	23.11	33.15	2.74	2.43	1.22	1.52	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	30.53	34.50	2.82	3.76	3.14	1.99	1.25	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	32.49	29.64	3.73	3.51	1.76	1.76	1.32	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	26.09	28.34	3.09	2.81	2.52	1.12	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	20.55	25.92	3.52	2.50	2.31	1.76	1.39	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	25.40	21.39	1.87	1.60	1.60	1.87	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	23.26	31.83	3.37	2.45	3.37	1.84	1.07	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.15	33.29	2.46	1.94	1.55	1.30	0.78	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	32.53	29.55	4.34	1.90	2.71	1.08	1.08	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	25.07	34.66	3.13	3.32	1.84	0.74	0.92	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	29.39	28.07	1.75	1.32	1.32	2.19	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	39.67	27.77	5.95	0.99	1.98	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.92	28.23	2.37	1.32	1.32	0.66	1.06	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	17.15	27.04	1.21	1.41	1.21	1.01	1.21	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	31.52	25.92	7.37	4.57	3.56	1.02	1.02	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	79.82	41.80	6.37	11.94	3.78	2.59	4.38	1.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	34.20	22.80	6.47	9.09	2.93	2.47	3.08	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	52.17	33.14	6.34	9.41	3.89	4.09	4.71	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	32.54	16.27	4.69	3.76	1.56	0.00	0.94	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	30.80	14.98	2.83	2.54	0.28	1.70	0.28	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	49.35	20.29	2.77	6.92	1.84	0.92	3.69	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	27.22	2.47	2.47	0.00	2.47	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	40.23	24.37	3.09	4.25	1.16	3.48	1.55	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	33.69	46.53	3.21	3.21	3.21	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	20.87	17.39	3.48	1.74	6.96	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	31.57	24.41	4.56	4.56	2.93	4.23	2.93	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	38.71	30.06	1.65	5.77	2.47	2.06	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	13.33	13.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	34.40	24.61	3.64	2.24	1.96	3.64	2.24	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	37.26	26.80	5.23	5.56	2.61	2.94	2.29	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	25.17	10.07	4.19	2.52	1.68	1.68	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.22	21.63	5.41	2.23	3.50	2.86	1.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	32.61	26.15	2.38	3.40	1.02	2.38	2.04	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	10.44	4.18	6.26	4.18	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	25.77	17.18	3.44	2.86	2.29	3.44	2.86	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	19.24	15.10	1.78	3.55	1.18	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	23.72	3.39	1.69	0.00	3.39	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	24.02	33.97	3.73	2.07	3.31	2.07	2.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	26.46	28.77	5.29	3.68	3.22	2.76	0.69	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	26.34	5.27	15.81	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.61	19.22	3.46	3.84	2.69	2.69	2.69	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	19.88	27.06	3.26	2.28	1.96	1.63	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	18.06	14.71	4.68	3.34	1.34	1.34	3.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	26.58	25.81	2.31	3.08	1.16	1.93	2.31	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.70	32.18	3.77	4.11	1.71	1.71	0.68	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	14.91	2.48	4.97	2.48	2.48	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	33.50	23.59	2.36	6.13	0.94	1.42	2.36	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	36.81	31.38	4.22	3.02	0.60	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	20.35	19.33	2.03	4.07	5.09	2.54	1.02	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	28.32	20.34	1.99	4.79	3.59	1.99	1.60	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	32.07	18.75	4.44	4.93	2.47	2.96	1.97	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	24.79	10.62	1.18	2.36	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	17.50	21.00	3.50	5.83	1.17	0.58	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	29.41	27.65	5.71	6.14	1.32	0.44	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	17.80	25.43	4.24	0.00	0.00	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	12.54	14.92	1.19	2.98	0.60	1.79	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	23.29	21.84	4.85	3.88	0.97	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	10.27	3.42	1.14	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	8.32	14.55	0.83	0.42	0.42	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	6.75	10.12	3.37	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	12.05	15.86	2.22	0.63	0.00	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.70	13.37	2.09	0.84	0.00	0.00	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	38.99	40.38	4.64	4.99	2.09	2.09	0.93	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	42.54	40.85	6.92	4.73	3.04	3.04	1.35	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	36.17	40.27	3.41	5.92	4.10	3.41	2.28	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	38.04	44.49	5.03	5.03	2.51	1.53	0.98	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	46.85	37.39	5.80	6.45	3.44	2.79	1.93	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	36.17	34.88	7.10	3.88	1.94	3.23	0.86	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	41.35	39.10	5.23	6.10	2.37	1.87	1.12	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	37.91	43.57	6.35	4.63	2.23	1.72	0.69	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	32.68	30.11	4.16	6.73	2.56	1.28	1.28	2.24
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	13.99	10.63	1.68	1.12	1.68	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.33	5.63	0.43	0.00	0.00	0.00	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	23.79	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	12.35	8.47	1.76	0.71	0.35	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.18	7.99	0.73	1.45	0.73	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	21.33	22.03	4.02	1.92	2.10	1.22	1.75	0.35
Hepatocyte, donor1	11523-119I2	27.84	26.63	4.84	8.47	1.21	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	18.31	36.63	0.00	2.15	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	35.59	35.59	4.91	5.52	0.61	0.61	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	8.48	5.22	1.96	2.61	1.31	2.61	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	49.64	37.23	5.24	5.24	1.75	1.75	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	40.06	25.11	5.35	3.70	1.37	0.96	0.41	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	27.08	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	12.46	2.77	0.00	0.00	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00	0.00	0.00	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	23.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	12.81	0.00	0.00	0.00	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	4.87	11.37	4.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	1.67	3.33	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	17.21	3.97	0.00	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	11.09	3.33	0.00	1.11	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	3.15	1.89	0.00	0.00	0.63	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	9.28	0.00	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	8.40	8.40	0.00	0.00	0.00	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	4.83	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.96	8.15	0.00	1.63	0.00	0.00	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	3.78	2.52	0.42	0.00	0.42	0.42	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	7.23	4.02	0.80	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	1.85	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	2.36	0.47	1.89	0.00	0.00	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	4.53	0.91	1.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	8.61	6.46	0.00	1.08	0.00	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	11.43	3.81	1.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2.55	3.19	1.91	2.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	1.82	0.00	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.14	2.86	0.00	0.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	9.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	7.72	5.25	0.62	1.54	0.00	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	7.02	0.00	3.51	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	0.00	0.00	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.04	5.56	0.70	0.00	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	15.49	0.00	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	19.45	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	6.98	0.87	0.87	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	9.00	0.00	0.00	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	6.97	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	4.27	0.00	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	4.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	5.70	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	5.52	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	6.05	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	12.42	0.00	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	8.46	1.06	2.11	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	22.03	38.60	2.94	2.37	0.49	0.16	0.24	0.33
Keratinocyte - epidermal, donor2	11349-117G8	16.40	13.47	1.76	0.59	0.00	0.59	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	41.84	42.69	5.40	3.98	1.89	1.04	1.23	0.76
Keratinocyte - oral, donor1	11251-116E9	87.52	91.95	10.44	9.42	4.09	2.95	1.93	1.14
Keratocytes, donor1	11527-119I6	5.50	6.88	0.00	0.34	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	4.69	4.69	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	12.84	15.41	1.38	2.17	0.20	0.40	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	19.78	2.20	28.57	2.20	2.20	15.39	0.00
Lens Epithelial Cells, donor1	11529-119I8	18.34	28.05	2.16	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	50.98	24.45	6.11	4.61	1.38	1.27	1.27	0.46
Lens Epithelial Cells, donor3	11690-122I7	55.50	30.47	4.84	3.03	1.92	1.21	0.40	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	17.31	15.65	3.08	1.19	0.71	0.71	0.36	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.09	12.00	1.12	0.28	0.56	0.28	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	16.06	25.82	2.83	1.42	0.63	0.63	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	6.99	0.00	1.61	1.08	1.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2.52	5.99	0.63	1.58	1.26	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.96	7.76	0.54	0.32	0.65	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.67	14.36	1.64	0.82	1.23	1.23	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.03	2.28	0.25	0.25	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.76	7.04	0.70	0.42	0.56	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.49	17.40	1.19	0.40	0.79	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.17	9.69	1.55	0.19	0.58	0.39	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.63	3.52	0.56	0.19	0.00	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.71	16.38	1.74	2.44	0.70	1.05	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.44	11.45	1.43	1.19	0.24	0.48	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.73	7.83	0.69	0.41	0.69	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.93	15.09	1.23	0.92	1.54	0.92	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.68	5.30	0.00	0.31	1.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.77	7.32	0.37	0.00	0.18	0.18	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.85	11.85	1.32	1.65	0.00	0.66	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.22	7.03	0.29	0.88	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.97	5.48	0.00	0.25	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.24	11.64	0.48	1.45	0.48	0.97	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.73	9.16	1.89	0.81	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.08	8.48	1.06	0.45	0.76	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.22	10.37	1.04	1.56	0.52	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.28	13.61	0.84	1.47	1.47	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.22	8.27	0.75	0.30	0.30	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.94	14.45	0.00	0.00	0.00	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.71	10.54	0.56	0.38	0.56	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.73	4.67	0.53	0.53	0.21	0.11	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.63	14.54	1.45	1.94	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.95	5.95	0.99	0.99	0.99	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.97	5.33	0.50	0.12	0.37	0.25	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	15.92	19.62	1.11	0.74	0.00	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.18	9.88	0.49	0.49	0.49	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.61	5.64	0.69	0.69	0.27	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.12	15.12	2.25	1.29	1.29	1.29	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.00	15.83	0.61	1.22	0.61	1.22	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	10.22	13.58	0.98	0.56	0.70	0.00	0.28	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	10.67	12.09	1.42	1.42	0.36	0.36	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.91	4.36	0.00	1.45	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.49	2.49	0.31	0.00	0.00	0.00	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.52	10.03	2.15	1.07	1.07	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.86	8.17	0.33	0.33	0.65	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.12	3.06	0.47	0.00	0.24	0.47	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	15.35	13.74	1.73	1.86	0.37	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.31	2.82	0.26	0.00	0.26	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.37	5.67	0.60	0.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	4.53	4.53	4.53	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	21.48	13.81	3.07	3.07	1.53	1.53	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	18.56	4.45	5.94	2.23	0.00	2.23	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.54	8.89	2.54	2.12	1.27	1.27	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	20.40	6.33	3.52	0.70	0.70	0.70	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	26.15	7.47	5.60	1.87	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	17.52	8.24	1.55	2.06	0.52	0.52	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	9.52	1.19	0.00	2.38	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.29	9.05	7.46	2.26	1.13	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	21.81	14.54	3.49	1.74	0.87	1.45	1.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	25.21	15.76	4.95	2.70	0.45	0.45	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	25.88	13.55	4.47	3.66	1.35	1.22	0.95	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.51	8.22	2.05	3.08	1.03	0.00	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	32.82	9.88	3.53	3.18	1.76	0.35	1.76	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.00	7.33	4.00	2.00	0.00	0.67	0.67	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	20.38	15.28	4.08	4.58	0.00	1.02	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	28.28	15.74	6.14	2.40	1.33	0.80	0.80	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.56	13.98	5.67	4.35	0.19	0.76	0.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.25	7.36	4.91	3.68	0.00	1.84	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	36.69	13.05	7.34	0.82	0.82	0.82	3.26	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	29.36	16.45	3.54	2.29	1.25	0.42	2.08	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	26.34	11.77	3.92	3.08	1.96	1.12	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	37.09	11.33	7.21	1.03	1.03	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	31.93	13.93	5.23	1.74	1.74	0.87	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	24.81	9.86	2.69	3.29	0.30	0.00	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	34.86	11.62	2.77	4.98	0.00	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	35.00	12.37	7.07	4.24	0.35	1.41	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	18.44	11.80	2.58	3.32	0.00	1.84	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	9.21	2.30	6.91	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	26.48	10.75	3.07	4.61	1.15	1.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	16.98	15.85	2.26	1.13	1.13	0.57	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	13.95	4.92	3.28	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	26.66	16.72	2.71	4.07	0.90	0.45	1.81	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	21.54	8.62	5.75	2.15	0.00	0.72	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	32.12	11.95	4.48	2.99	1.49	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	24.53	14.12	1.86	4.83	1.11	1.49	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	23.26	11.20	2.58	4.31	0.43	0.86	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	32.54	5.14	4.28	1.71	0.86	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	28.32	11.66	3.00	4.00	1.00	0.67	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	19.91	6.64	1.81	4.22	0.60	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.17	6.40	4.27	0.71	0.00	1.42	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	28.18	13.40	2.75	3.44	0.69	0.69	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.01	10.73	2.68	2.68	0.54	1.61	1.07	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	18.85	10.77	4.71	2.69	0.67	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.19	18.15	3.33	4.44	0.74	0.74	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	27.91	10.47	3.49	2.33	1.16	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	4.23	1.06	1.06	0.00	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	19.21	13.61	4.40	2.40	1.60	1.20	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	21.81	6.54	3.63	3.63	1.45	2.18	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	25.30	13.80	8.43	4.60	2.30	1.53	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	23.68	11.84	2.96	3.45	0.00	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	8.47	3.76	0.00	0.00	0.94	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	30.67	14.58	6.03	4.02	0.50	0.50	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	22.08	13.97	4.96	4.06	1.80	0.90	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	10.33	1.72	1.72	0.00	3.44	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	27.61	10.24	3.56	2.67	0.00	1.78	0.00	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.03	15.64	3.13	3.13	0.78	1.17	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.17	10.56	3.96	2.64	1.32	0.66	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.54	14.01	2.08	4.15	1.04	1.56	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	36.76	17.50	4.38	3.06	0.44	0.44	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	21.80	13.98	2.24	3.91	1.68	1.12	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	24.73	15.90	4.42	3.97	0.44	0.00	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	25.46	13.11	5.40	1.93	0.77	0.39	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	23.80	13.67	6.08	2.53	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	29.80	14.42	6.25	3.84	0.00	1.44	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	24.65	13.12	3.58	3.98	0.80	0.80	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.84	8.51	2.43	4.86	0.00	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	8.99	4.15	4.84	1.38	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	28.50	14.06	7.60	4.94	1.14	0.38	1.90	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	20.66	5.68	4.13	3.61	1.03	1.03	1.03	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	19.95	9.07	2.42	1.81	0.60	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	29.15	13.63	2.54	3.80	0.63	1.58	1.27	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.46	9.60	3.73	1.07	1.60	1.07	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.94	10.92	1.15	3.45	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.08	11.31	2.57	2.57	0.00	1.54	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	23.34	3.54	1.41	2.83	1.41	0.71	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	20.43	9.08	1.70	1.70	1.13	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	25.79	12.48	3.74	2.91	0.83	0.83	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	11.75	11.75	1.57	2.35	1.57	3.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	21.29	7.93	2.51	2.51	1.67	1.25	0.84	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	21.37	15.80	5.58	4.18	1.39	2.32	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.04	9.37	2.68	2.68	0.00	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.06	9.62	1.60	2.67	0.53	1.07	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	27.48	12.12	3.64	7.27	2.02	0.81	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	16.52	2.75	2.75	5.51	0.00	0.92	0.92	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	17.78	9.78	4.45	2.67	1.78	2.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.92	15.39	5.13	0.57	0.00	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.94	9.97	0.77	4.60	2.30	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	19.15	16.96	2.19	2.19	1.64	1.09	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	25.39	10.25	5.35	3.56	0.89	1.78	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.66	10.14	4.42	2.08	0.78	0.26	1.82	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	27.19	11.94	3.32	2.65	0.00	0.00	1.33	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	16.63	4.16	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	38.97	26.67	3.42	2.28	2.51	0.46	0.91	0.68
Macrophage - monocyte derived, donor2	11313-117C8	33.03	17.98	4.04	2.02	2.20	1.10	1.28	0.73
Macrophage - monocyte derived, donor3	11389-118C3	33.56	21.37	3.67	1.44	2.23	1.57	1.44	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.15	23.36	1.59	1.06	0.53	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	31.69	51.34	4.12	3.17	1.43	0.79	0.00	0.48
Mallassez-derived cells, donor3	11930-125I4	34.19	49.90	4.59	4.59	0.83	1.11	0.69	1.53
Mammary Epithelial Cell, donor1	11273-116H4	62.18	38.26	7.47	6.68	3.79	2.69	2.29	1.20
Mammary Epithelial Cell, donor2	11350-117G9	55.88	32.72	6.95	8.69	2.32	2.61	0.29	1.74
Mammary Epithelial Cell, donor3	11422-118F9	17.96	10.23	2.24	1.00	1.50	0.25	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	40.00	96.94	12.20	13.56	37.29	8.81	4.75	2.03
Mast cell, donor1	11563-120D6	50.61	30.82	7.57	7.57	3.03	1.19	1.73	1.41
Mast cell, donor2	11565-120D8	70.13	60.33	7.73	10.10	12.18	4.46	4.16	1.19
Mast cell, donor3	11566-120D9	126.52	73.62	8.78	18.01	14.18	6.08	6.30	1.80
Mast cell, donor4	11567-120E1	72.69	43.79	7.98	10.64	10.81	4.25	2.66	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	72.19	56.33	9.09	8.87	8.10	2.77	2.55	2.22
Mast cell, expanded and stimulated, donor8	11942-126A7	35.02	41.44	4.67	5.84	4.67	4.67	4.09	0.58
Mast cell, expanded, donor5	11939-126A4	29.94	20.88	5.39	4.13	1.72	0.46	1.03	0.69
Mast cell, expanded, donor8	11941-126A6	44.18	34.98	4.02	4.85	3.68	0.67	1.34	1.84
Melanocyte - dark, donor1	11502-119F8	32.24	23.78	3.58	1.79	1.09	0.60	0.70	0.50
Melanocyte - dark, donor2	11582-120F7	21.80	21.11	3.81	0.69	0.69	0.35	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	53.46	30.35	4.85	4.13	4.27	3.04	1.74	0.65
Melanocyte - light, donor1	11274-116H5	23.51	15.28	1.18	0.94	0.94	0.24	0.00	0.71
Melanocyte - light, donor2	11351-117H1	6.82	4.78	0.00	0.68	0.68	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.01	6.94	0.00	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	23.01	22.80	3.23	1.67	1.04	0.52	0.83	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	20.44	31.20	1.88	1.34	2.42	0.54	0.81	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	24.11	28.93	1.61	0.80	0.27	0.00	0.27	0.80
Meningeal Cells, donor1	11493-119E8	21.09	11.91	1.86	2.11	1.98	0.50	0.74	0.50
Meningeal Cells, donor2	11573-120E7	19.37	10.56	0.44	1.32	1.32	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	29.59	33.50	3.83	4.08	1.79	1.30	0.65	0.98
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	43.63	23.95	8.27	4.28	3.99	0.57	0.29	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.96	12.38	2.11	1.51	0.10	0.20	0.20	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	0.00	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	18.66	17.94	2.15	2.15	2.15	0.00	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	36.42	23.72	4.45	2.33	0.64	0.85	0.21	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	13.07	19.10	2.01	1.01	0.50	0.50	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.55	4.61	1.76	1.54	1.10	0.44	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	11.69	5.84	1.46	0.73	0.73	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.55	6.14	1.43	0.41	0.41	0.20	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	33.66	20.50	3.46	3.19	1.11	0.42	0.55	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.83	5.95	0.00	0.00	1.86	0.74	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	21.32	35.00	2.76	1.71	2.37	0.79	0.66	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.56	11.57	0.89	0.00	2.08	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	14.01	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	6.40	0.00	0.64	0.00	0.64	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.38	25.52	2.84	2.84	1.77	0.35	0.35	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.96	35.03	0.63	2.19	1.88	1.88	0.94	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.05	11.61	5.08	4.35	2.90	2.18	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	10.87	27.05	2.92	1.33	0.53	0.27	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	7.51	19.52	2.00	0.50	0.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	13.44	26.59	2.38	1.88	0.65	0.14	0.14	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	21.61	4.05	2.70	6.75	2.70	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.19	26.35	3.45	2.46	0.74	0.74	0.74	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.13	17.96	4.12	1.77	3.83	0.59	0.88	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	31.11	6.91	6.91	3.46	10.37	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.74	25.42	3.72	1.86	1.24	2.17	1.24	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.65	16.18	3.11	2.07	2.07	0.83	0.83	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	16.21	0.00	2.32	2.32	9.26	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	22.02	22.52	2.75	1.50	2.00	0.50	1.00	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.96	22.34	4.19	1.86	2.79	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	17.88	25.61	3.86	1.42	1.22	1.02	0.41	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	14.25	16.63	1.58	1.98	2.38	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	51.31	34.21	25.65	34.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	17.70	12.39	0.00	0.88	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	17.86	12.54	1.90	0.38	0.38	0.76	1.90	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	25.00	11.84	5.26	9.21	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.70	20.16	2.12	2.76	0.85	0.42	0.21	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	8.29	16.57	1.84	1.84	1.84	0.00	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	16.99	18.18	1.79	2.38	2.38	0.89	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	11.74	3.35	3.35	5.03	1.68	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.54	14.55	2.01	1.76	1.76	0.50	1.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	20.20	18.78	2.14	0.48	0.71	0.95	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.42	22.12	6.63	4.42	5.53	2.21	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.74	17.50	1.61	1.15	1.61	0.46	0.69	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.84	11.15	2.10	1.89	1.26	0.63	0.84	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.56	12.64	2.45	1.83	1.43	1.02	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.23	15.02	3.22	1.29	1.50	0.21	0.64	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	17.12	14.45	2.89	3.33	1.33	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	30.96	10.32	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.39	16.86	1.75	2.19	1.75	0.00	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.63	11.66	3.04	3.55	2.03	1.52	2.03	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	13.26	4.97	1.66	9.94	1.66	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	12.23	21.47	5.44	0.82	2.45	0.54	1.36	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.41	18.23	3.23	1.76	1.76	1.18	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	16.35	2.18	4.36	2.18	2.18	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.05	21.14	3.36	2.40	0.96	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.60	8.40	0.80	1.60	2.80	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	21.94	5.48	2.74	2.74	2.74	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.51	25.03	0.00	0.50	1.50	1.00	1.00	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	20.39	6.12	6.12	2.04	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	13.14	21.90	1.31	3.07	0.88	0.44	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	7.73	8.83	2.21	0.00	1.10	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.33	24.98	8.33	5.12	5.76	1.28	1.28	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.14	23.30	2.48	0.00	0.74	0.25	0.50	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	6.26	6.26	1.39	2.09	2.09	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	37.57	4.42	2.21	4.42	2.21	4.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	20.51	28.72	2.05	1.37	0.68	1.03	1.03	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	7.88	4.38	1.31	1.75	0.88	2.19	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.52	53.97	2.49	2.13	2.49	3.20	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	14.87	30.86	3.93	1.96	1.40	0.84	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.40	11.22	3.74	1.25	0.42	0.83	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	32.63	5.83	4.66	5.83	2.33	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	17.80	28.05	3.92	2.11	1.21	2.41	0.30	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.85	12.94	1.25	1.25	2.50	0.83	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	57.75	21.66	7.22	0.00	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	41.56	5.54	0.92	0.92	0.00	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.83	19.35	4.55	0.00	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.74	26.95	3.04	1.66	2.35	1.80	0.83	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.88	25.91	1.30	1.30	2.59	1.04	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	19.30	25.74	6.01	1.72	1.29	0.86	1.29	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.91	18.42	5.72	0.64	3.81	1.27	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.55	36.56	4.27	1.60	2.40	2.14	0.53	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.27	27.24	3.59	1.80	0.90	0.90	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.56	38.99	2.40	1.70	3.81	1.13	1.13	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	16.56	35.35	4.46	2.23	2.23	2.23	0.64	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	20.34	23.88	3.54	1.99	1.55	1.33	0.88	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.86	31.09	3.03	1.90	3.41	3.41	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	18.18	40.06	3.98	1.14	1.70	2.27	0.57	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	14.01	22.37	1.97	2.70	0.98	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	8.47	57.35	5.21	3.26	1.96	3.26	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.76	41.46	4.41	1.18	2.94	0.88	0.29	1.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.42	28.26	3.17	2.88	0.29	0.86	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	24.32	46.16	7.01	2.47	2.06	0.41	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.57	33.35	3.57	1.79	2.98	1.79	0.89	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	12.48	3.56	0.00	0.00	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	22.01	25.30	0.33	0.33	0.33	0.33	1.97	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	8.42	13.68	3.16	3.16	3.16	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	8.70	18.19	1.98	0.99	0.99	0.59	0.59	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	19.56	20.49	3.73	5.59	1.86	1.86	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.77	14.65	1.50	0.75	1.13	0.75	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	15.98	13.32	3.20	1.60	0.80	1.07	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.14	14.14	1.81	1.58	1.02	0.23	0.45	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	9.58	11.05	1.47	1.47	0.74	0.00	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	10.63	19.05	0.37	1.10	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	14.00	3.11	0.00	3.11	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	18.71	2.14	2.67	4.28	1.60	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	7.73	3.86	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	16.16	4.04	1.01	0.00	1.01	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.07	15.60	2.53	1.69	1.26	1.69	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	16.34	5.45	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.90	15.26	2.54	4.45	3.18	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	30.77	18.63	4.05	2.43	1.62	1.62	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	22.66	4.53	6.04	3.02	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	28.55	0.00	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	26.10	3.26	3.26	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	4.75	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	23.27	19.17	5.39	3.88	1.94	1.51	0.43	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	34.49	25.61	6.79	1.57	2.09	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	7.34	12.68	2.67	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.02	7.51	2.92	2.50	0.42	0.00	0.42	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	31.37	23.58	9.51	4.37	1.33	0.95	0.57	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	27.13	35.11	11.17	9.58	1.60	6.38	4.79	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	11.56	0.68	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	47.78	60.64	31.24	3.68	3.68	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.23	19.25	1.26	0.84	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.71	10.92	4.18	2.56	0.93	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.51	16.21	1.62	1.35	0.27	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	22.92	22.29	2.73	2.10	1.26	0.42	1.05	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	111.35	211.56	0.00	0.00	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.90	13.90	0.50	1.49	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.95	22.47	4.06	1.35	0.81	0.54	0.00	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.47	9.52	1.36	0.68	0.00	0.23	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.10	14.21	1.47	0.65	0.49	0.49	0.49	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.23	29.89	3.28	3.28	0.36	0.00	0.00	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	12.73	1.06	1.59	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.60	10.21	2.40	0.00	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.72	28.88	4.27	2.30	0.66	0.00	0.66	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.22	8.29	1.46	0.98	0.16	0.33	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.76	28.57	3.17	2.29	0.35	0.00	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	10.55	0.70	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.39	17.01	1.38	0.92	0.00	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.89	14.14	1.61	1.29	0.32	0.00	0.64	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	20.69	26.21	6.21	2.76	0.34	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	78.38	85.97	15.17	10.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.94	26.51	4.23	2.67	0.67	0.00	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.09	17.36	1.69	0.85	0.42	0.00	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.48	23.50	2.14	2.14	0.00	0.00	0.47	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	17.60	12.02	3.00	1.29	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	135.42	144.44	9.03	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.00	8.66	1.00	1.33	0.00	0.33	1.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.94	24.35	1.35	3.61	0.45	0.00	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	10.32	12.30	1.59	1.98	0.00	0.00	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	9.29	0.93	0.00	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.54	19.30	4.92	2.27	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.36	7.82	1.63	0.65	0.00	0.00	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.72	8.28	2.18	0.87	0.44	0.00	0.87	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.00	30.30	5.43	1.36	1.81	0.45	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	8.82	3.53	1.76	0.88	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	8.64	11.97	0.66	0.66	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	8.93	0.99	2.48	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.25	6.13	0.38	0.38	0.38	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.01	18.45	2.42	0.91	0.30	0.60	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.96	24.31	3.98	3.09	0.22	0.44	0.00	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	11.52	2.03	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	66.42	10.22	0.00	0.00	0.00	10.22	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	15.24	12.80	4.27	0.00	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	8.50	4.72	2.83	1.26	0.00	0.31	0.94	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.29	12.41	3.33	0.91	0.00	0.00	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	21.36	14.24	0.00	1.58	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	34.01	20.41	11.34	4.53	0.00	0.00	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	75.87	111.27	10.12	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	19.75	24.10	3.11	0.37	0.37	0.75	0.25	0.25
Myoblast, donor2	11322-117D8	35.86	39.70	4.99	2.30	0.19	1.15	1.15	0.77
Myoblast, donor3	11398-118D3	45.07	35.15	5.89	3.53	1.85	1.68	1.01	2.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	59.25	19.12	7.73	11.97	0.58	1.61	2.63	0.88
Natural Killer Cells, donor1	11230-116C6	58.43	66.42	3.08	5.54	1.54	2.46	3.08	1.85
Natural Killer Cells, donor2	11311-117C6	45.84	74.48	1.51	4.82	1.51	2.11	1.21	1.21
Natural Killer Cells, donor3	11387-118C1	42.15	71.41	3.50	4.42	1.10	0.74	1.47	1.66
Neural stem cells, donor1	11275-116H6	21.78	49.72	6.90	4.72	10.53	3.27	3.99	0.00
Neural stem cells, donor2	11352-117H2	23.11	42.36	5.78	3.85	9.63	11.55	3.85	1.93
Neurons, donor1	11494-119E9	51.21	56.89	3.41	6.83	5.69	3.41	3.41	0.00
Neurons, donor2	11574-120E8	50.42	42.05	6.60	5.94	1.54	0.00	0.22	1.98
Neurons, donor3	11655-122E8	41.93	48.51	8.22	3.29	2.47	1.64	0.82	0.00
Neutrophils, donor1	11233-116C9	142.91	186.53	9.28	18.56	32.48	12.06	11.14	3.71
Neutrophils, donor2	11314-117C9	118.85	127.55	8.70	5.80	11.60	5.80	2.90	0.00
Neutrophils, donor3	11390-118C4	259.61	254.11	19.55	27.49	51.92	23.82	17.10	4.28
Nucleus Pulposus Cell, donor1	11252-116F1	44.05	39.18	6.29	5.58	1.90	1.19	0.95	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	19.54	19.86	2.93	2.28	0.00	0.00	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	25.67	19.25	2.01	3.01	0.60	0.40	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	14.32	20.37	2.06	0.96	0.28	0.55	0.55	0.00
Olfactory epithelial cells, donor2	11934-125I8	21.42	24.46	3.33	1.30	0.43	0.14	0.58	0.43
Olfactory epithelial cells, donor3	11935-125I9	17.14	19.86	2.95	1.14	0.23	0.11	0.34	0.45
Olfactory epithelial cells, donor4	11936-126A1	29.61	28.44	2.14	1.75	0.39	0.00	0.00	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	52.36	54.77	3.01	1.20	1.81	2.41	0.00	1.81
Osteoblast - differentiated, donor1	11276-116H7	24.67	20.21	2.55	1.28	0.64	0.43	0.21	0.64
Osteoblast - differentiated, donor2	11353-117H3	8.00	6.86	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	8.69	19.86	1.24	0.00	0.62	0.00	1.24	0.62
Osteoblast, donor1	11277-116H8	9.77	5.08	1.17	0.39	0.59	0.00	0.20	0.39
Osteoblast, donor2	11354-117H4	49.16	26.69	9.83	3.51	2.11	2.11	2.11	0.70
Osteoblast, donor3	11426-118G4	31.10	19.02	5.69	3.91	1.96	0.89	1.60	0.71
Pancreatic stromal cells, donor1	11249-116E7	30.49	33.69	3.29	2.36	1.10	0.59	0.93	0.34
Pericytes, donor1	11491-119E6	4.67	2.23	0.56	0.33	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	6.56	4.30	0.68	0.45	0.23	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	9.36	9.77	0.61	0.81	0.00	0.20	0.20	0.20
Perineurial Cells, donor1	11499-119F5	38.77	24.53	4.18	3.84	1.36	0.79	0.68	0.45
Perineurial Cells, donor2	11579-120F4	40.12	30.27	3.77	3.22	2.12	1.56	1.01	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	75.22	67.25	4.14	9.24	6.69	4.14	1.91	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	42.61	91.58	5.14	3.67	5.14	1.22	1.71	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	55.26	62.38	3.88	6.08	2.72	1.42	2.07	1.29
Placental Epithelial Cells, donor1	11278-116H9	11.48	13.87	0.96	1.20	1.20	0.24	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	7.76	8.87	1.11	3.33	1.11	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	8.25	9.03	1.37	0.20	0.20	0.20	0.39	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.44	12.66	2.22	1.90	0.00	0.32	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	9.19	9.38	2.63	1.50	0.19	0.94	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	21.01	12.79	5.87	3.52	0.39	0.26	0.13	0.26
Preadipocyte - breast, donor2	11328-117E5	15.99	12.61	2.03	3.38	0.45	0.45	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	16.30	18.54	3.30	2.66	0.32	0.32	0.85	0.11
Preadipocyte - omental, donor2	11329-117E6	12.66	13.09	7.42	2.18	1.31	1.75	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	26.50	15.61	5.16	2.44	0.29	0.14	0.43	0.14
Preadipocyte - perirenal, donor1	11469-119C2	19.69	5.91	1.97	0.98	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	14.13	8.29	1.84	0.31	0.00	0.61	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	33.29	41.44	4.25	2.66	1.42	1.42	0.89	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	22.82	20.26	2.55	1.87	0.51	0.34	0.17	0.34
Preadipocyte - visceral, donor1	11280-116I2	31.86	32.60	4.66	3.07	1.68	0.84	0.28	0.56
Preadipocyte - visceral, donor2	11357-117H7	26.23	32.21	0.92	0.46	0.46	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	20.48	17.97	1.99	1.46	0.52	0.21	0.52	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	35.75	21.12	6.94	7.39	1.96	1.36	1.66	0.15
Prostate Epithelial Cells, donor2	11331-117E8	21.26	22.48	4.33	1.49	0.27	0.68	0.41	0.27
Prostate Epithelial Cells, donor3	11404-118D9	66.63	35.40	7.59	4.78	1.35	0.73	0.67	0.61
Prostate Stromal Cells, donor1	11254-116F3	21.19	27.79	3.42	2.28	0.57	0.80	0.68	0.23
Prostate Stromal Cells, donor2	11332-117E9	17.93	23.85	2.87	1.61	0.72	0.54	0.54	0.36
Prostate Stromal Cells, donor3	11405-118E1	11.05	15.95	1.36	1.04	0.52	0.52	0.21	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.60	7.66	0.73	1.46	1.09	0.00	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	33.20	43.74	3.60	3.19	2.43	1.94	0.97	0.35
Renal Epithelial Cells, donor1	11517-119H5	10.14	4.57	0.51	0.00	1.52	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.96	4.27	0.71	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	35.04	46.79	5.72	3.49	2.54	1.48	0.64	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	4.09	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.05	9.16	1.21	0.94	0.67	0.67	0.54	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	25.75	34.19	4.44	2.44	3.33	1.11	0.67	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	0.67	3.33	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.36	5.50	1.10	0.22	0.00	1.10	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	14.42	11.91	1.25	1.25	0.63	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.33	3.05	0.28	0.00	0.55	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	33.02	20.94	2.95	2.42	3.22	0.81	1.61	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	12.23	16.02	1.27	0.42	0.42	0.42	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.15	10.80	1.74	1.35	1.16	0.58	0.77	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	47.19	29.04	7.52	6.22	2.59	2.07	1.04	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	11.65	7.67	0.85	1.14	0.85	0.28	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	4.12	0.00	0.00	1.03	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	18.82	20.57	1.76	3.51	1.00	1.00	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	81.25	85.53	6.55	6.01	3.74	0.80	1.20	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	18.76	18.76	2.68	4.47	0.89	1.79	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	33.02	21.46	1.65	2.75	0.55	2.20	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	40.02	33.64	5.22	6.38	1.16	0.00	2.32	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	60.46	45.90	7.02	4.81	2.47	1.95	0.65	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	36.74	37.24	5.16	3.08	0.79	0.89	0.30	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	49.75	38.15	7.47	4.35	1.67	1.23	1.45	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	70.08	54.58	6.33	3.97	1.61	1.74	0.50	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	38.81	39.97	5.13	3.26	0.93	1.40	0.82	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	40.91	49.00	5.78	3.70	0.92	1.85	0.69	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	44.77	37.51	4.79	3.15	0.96	1.10	0.27	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	36.00	37.52	4.99	3.48	0.91	0.61	0.76	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	58.60	37.81	7.88	4.30	1.08	0.54	0.90	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	42.18	35.58	4.16	3.16	1.72	2.01	0.43	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	32.41	34.56	4.51	3.43	1.40	1.18	0.32	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	40.27	39.61	5.75	3.76	1.55	1.33	1.11	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	36.51	30.97	5.74	2.87	1.53	0.76	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	36.80	36.24	4.84	3.35	1.86	1.30	0.47	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	52.43	40.21	4.89	5.26	1.50	1.69	0.94	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	40.34	40.21	5.04	5.44	1.33	1.86	0.93	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	43.61	41.18	6.13	3.60	1.75	1.27	0.58	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	38.57	31.32	7.07	4.20	2.10	0.95	0.76	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	43.14	36.95	4.91	3.52	1.50	1.17	0.53	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	33.64	34.48	5.61	5.33	1.68	1.12	1.12	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	45.80	39.82	6.15	2.91	1.20	1.54	1.03	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.01	36.65	4.92	4.01	1.09	1.64	0.18	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	37.28	39.86	4.54	3.56	1.10	1.23	0.86	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	42.71	36.40	5.37	3.76	1.21	0.81	0.67	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	41.75	36.09	3.77	3.77	0.71	0.94	0.24	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	36.51	40.48	6.55	3.17	1.59	0.79	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	34.38	38.58	3.74	5.14	0.94	1.64	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	42.92	34.21	7.26	4.35	1.04	0.62	0.62	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	34.73	40.48	3.76	3.76	0.66	1.77	0.88	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	41.15	39.48	6.89	5.22	1.46	1.25	1.88	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	45.09	39.03	5.92	4.71	2.15	1.21	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	30.14	44.45	7.83	5.62	1.87	2.04	1.02	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	42.61	38.94	6.56	3.66	1.74	1.16	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	40.23	39.37	2.92	4.64	0.69	0.86	0.69	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	30.31	36.90	5.90	6.45	1.51	1.10	0.96	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	33.33	42.68	6.07	3.94	1.64	0.66	0.82	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	42.10	41.59	5.28	3.92	0.34	1.70	0.17	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	44.83	41.58	6.21	4.59	1.78	1.04	1.18	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	41.85	47.71	3.20	2.13	1.60	0.80	0.00	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	51.85	28.07	5.25	4.42	1.80	1.11	1.24	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	42.38	33.81	6.43	5.00	1.19	0.48	0.48	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	56.23	41.11	4.64	5.44	2.02	1.61	1.01	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	47.37	28.25	3.30	3.30	1.13	1.51	0.47	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	44.72	31.09	4.19	4.19	1.05	1.05	0.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	46.54	36.27	3.63	2.72	1.81	1.51	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	41.00	27.29	2.69	3.06	0.12	0.86	0.73	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	63.02	50.22	9.61	6.55	2.33	3.35	1.60	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	49.28	37.11	7.91	5.48	1.22	1.22	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	34.66	33.46	3.62	4.82	1.81	0.60	0.30	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	36.87	26.01	3.85	2.26	0.68	1.36	1.13	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	44.93	28.46	5.39	3.59	0.60	1.20	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	41.68	25.98	3.07	2.95	0.71	0.94	0.71	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	23.69	20.28	2.99	2.77	1.28	1.07	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	41.47	31.25	9.01	6.01	1.20	1.80	1.80	0.60
Schwann Cells, donor1	11498-119F4	9.22	4.14	0.75	0.38	0.94	0.19	0.00	0.38
Schwann Cells, donor2	11578-120F3	17.01	10.21	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	36.15	27.60	4.82	2.63	1.97	0.44	0.66	0.66
Sebocyte, donor1	11220-116B5	26.29	28.48	5.48	3.29	0.00	0.00	0.55	0.55
Sebocyte, donor2	11301-117B5	12.41	27.11	1.38	0.00	0.46	0.92	0.46	0.00
Sebocyte, donor3	11378-118B1	9.28	14.84	2.27	1.44	0.41	0.62	0.41	0.21
Sertoli Cells, donor1	11255-116F4	29.82	13.25	0.00	4.97	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	16.95	2.82	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	33.08	18.30	4.40	2.90	0.79	0.35	0.62	0.53
Skeletal Muscle Cells, donor2	11358-117H8	2.17	4.34	2.17	0.00	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	15.88	10.87	5.02	4.18	2.51	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	31.10	26.23	4.40	5.50	1.73	0.79	1.26	0.31
Skeletal Muscle Cells, donor5	11455-119A6	30.47	28.09	6.69	5.50	2.82	1.19	1.34	0.30
Skeletal Muscle Cells, donor6	11459-119B1	30.32	19.70	6.16	4.62	1.23	1.08	0.92	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	45.61	41.71	7.18	5.04	3.02	1.51	1.76	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.96	33.96	5.85	4.28	2.71	2.00	1.00	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	40.28	33.04	7.34	4.56	2.28	0.69	1.49	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	33.11	27.04	2.70	2.11	0.84	0.34	0.93	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	8.69	7.96	4.34	0.72	0.72	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.60	8.94	2.34	1.51	0.28	0.55	0.28	0.00
Skin - palm, donor1	10286-104F7	24.17	26.86	5.37	13.43	8.06	0.00	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.15	22.49	2.88	1.87	0.86	0.58	0.86	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	16.36	27.81	1.64	4.09	1.64	1.64	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.93	18.18	1.17	1.30	1.17	0.78	0.39	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	45.04	42.68	3.48	3.61	1.25	0.28	0.70	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	44.45	53.73	3.38	3.24	2.11	1.27	0.56	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	35.31	24.74	4.02	5.71	2.11	1.69	1.48	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	64.31	64.76	5.70	3.75	1.05	0.67	0.75	1.12
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.45	18.52	2.78	2.47	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	26.90	17.12	2.67	1.56	0.22	0.00	0.22	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	17.63	12.34	6.47	0.59	1.18	0.00	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	14.81	13.26	1.55	0.66	0.00	0.22	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	11.03	7.88	0.39	0.79	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	22.40	15.45	3.86	3.09	0.77	1.55	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	32.02	1.00	0.00	3.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	16.10	17.70	2.53	1.06	0.40	0.13	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	25.05	24.16	1.33	0.89	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	20.23	38.67	4.61	2.43	1.41	0.38	0.77	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.98	19.86	4.88	2.60	0.65	1.63	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	42.53	28.94	2.66	2.36	1.18	0.30	1.48	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	20.07	25.91	2.99	1.85	0.43	0.43	0.57	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.53	4.39	0.33	0.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.01	43.53	3.35	1.83	2.74	1.52	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.11	12.38	1.26	1.52	0.25	0.51	0.00	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.63	10.97	0.00	1.43	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	20.94	23.74	2.06	2.51	1.03	0.29	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	23.03	36.38	2.80	2.37	1.94	0.22	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	23.09	30.44	4.51	1.99	0.94	0.42	0.31	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.59	8.51	0.93	0.62	0.62	0.00	0.31	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	15.09	3.23	3.23	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.36	15.84	1.79	0.30	0.60	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.49	6.15	0.68	0.34	0.34	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.75	40.44	2.51	1.41	2.91	1.26	0.31	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	37.14	33.71	5.43	3.62	0.70	0.60	0.20	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	19.11	33.91	2.96	0.46	0.46	0.00	0.00	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	5.43	9.06	0.00	2.42	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	37.35	32.32	8.21	6.36	3.97	2.12	1.59	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	36.09	24.63	3.60	2.66	1.07	0.67	0.80	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.91	22.79	2.63	2.63	0.75	0.75	0.63	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.15	9.64	2.03	4.57	0.76	0.25	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	30.76	19.15	3.32	2.86	0.75	1.21	0.00	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.00	15.00	2.25	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	14.21	7.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	24.65	16.74	1.86	0.93	2.33	0.47	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	12.62	18.68	1.01	1.01	1.01	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	13.79	20.68	0.63	1.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.24	5.31	0.00	0.88	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	40.40	30.82	5.58	4.58	3.00	1.83	1.00	1.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.96	31.30	2.80	1.87	0.47	0.47	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	16.55	14.82	2.16	0.72	0.29	0.00	0.29	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	15.55	17.08	2.04	0.51	0.51	0.00	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.15	5.45	0.38	0.56	0.38	0.00	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	39.69	25.01	5.31	6.57	3.07	1.12	1.12	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	32.26	21.11	4.44	3.10	0.92	0.84	0.34	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	1.43	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	15.41	16.15	3.43	0.49	0.00	0.00	0.24	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	39.77	22.54	2.87	2.87	0.00	0.22	0.66	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.11	21.94	5.56	2.63	2.93	0.59	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.82	16.52	2.33	1.55	0.97	0.19	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.78	11.64	1.32	1.06	0.79	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	6.32	9.30	1.12	1.12	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.73	11.14	2.52	1.44	1.44	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.10	6.81	1.42	0.85	0.28	1.14	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.15	18.12	1.58	2.76	1.58	0.39	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	11.68	13.46	0.76	1.02	0.51	0.00	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	28.75	15.97	3.59	3.59	0.00	0.00	0.00	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	7.11	10.03	2.93	1.25	0.00	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	12.38	8.25	3.21	1.38	0.46	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	26.26	24.74	4.21	2.19	0.67	0.17	0.17	0.34
Synoviocyte, donor2	11368-117I9	20.79	25.65	2.01	1.68	0.34	0.17	0.00	0.17
Synoviocyte, donor3	11440-118H9	21.67	22.34	1.34	1.34	0.22	0.22	0.45	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	8.22	4.29	0.36	1.79	0.00	0.00	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	1.98	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.25	6.25	0.69	0.69	0.46	0.23	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	29.03	22.58	4.01	2.65	1.29	0.79	0.79	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	15.85	9.66	1.93	1.55	0.77	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.30	5.73	1.72	0.00	0.57	2.29	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	85.38	78.74	5.54	5.29	4.43	1.60	0.62	1.11
Urethra, donor2	10319-105A4	21.58	43.16	8.99	5.40	5.40	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	9.03	6.64	2.66	0.80	0.00	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	7.21	8.41	0.40	0.40	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	7.56	8.48	0.46	0.46	0.23	0.23	0.00	0.69
Urothelial cells, donor0	11216-116B1	61.07	69.10	4.46	3.79	2.45	0.89	0.67	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	277.61	73.85	6.23	6.23	8.90	3.56	2.67	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	310.23	102.93	7.15	14.30	14.30	0.00	2.86	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	148.54	84.20	5.48	2.74	4.79	0.68	0.68	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	119.49	54.75	6.20	4.48	4.48	1.72	1.72	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	95.29	47.06	8.72	6.39	6.97	1.74	0.00	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	238.44	72.89	7.29	18.74	9.37	6.25	4.16	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	283.60	81.68	11.01	8.26	9.18	2.75	3.67	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	144.24	83.99	4.56	5.48	5.48	0.91	0.91	1.83
Wilms' tumor cell line:G-401	10809-111A8	25.17	21.22	5.06	2.59	0.62	0.99	1.36	0.62
Wilms' tumor cell line:HFWT	10597-108E3	14.96	24.64	1.76	7.04	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	95.25	55.03	13.41	15.36	9.22	10.33	7.82	0.56
achilles tendon, donor2	10292-104G4	24.80	22.73	2.07	6.20	6.20	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	33.40	9.43	6.37	14.53	2.80	5.86	3.31	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	71.05	33.67	6.73	9.29	2.09	1.39	2.79	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	60.90	24.81	10.80	13.53	3.92	2.61	3.92	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	56.60	23.40	11.43	13.06	2.45	1.63	2.72	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	35.70	23.05	6.46	6.18	2.25	1.69	3.94	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	18.40	7.61	9.52	13.75	6.34	4.44	5.08	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.69	10.62	8.17	13.61	8.17	4.08	4.08	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	13.66	7.93	8.37	7.05	2.64	1.76	2.20	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	24.91	12.66	5.31	4.90	2.04	2.04	0.82	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	44.27	27.96	3.88	5.82	6.21	3.11	2.33	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	38.09	15.09	9.20	10.30	5.89	1.47	1.47	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	19.50	7.80	3.90	7.80	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	29.98	15.10	6.51	5.34	3.72	2.09	1.86	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	30.81	21.49	7.25	9.06	3.88	1.29	1.55	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	34.78	21.04	8.48	4.97	3.51	1.46	2.63	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	25.10	20.91	2.32	6.04	13.48	7.44	5.11	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	17.68	7.40	6.17	7.81	1.65	1.65	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.02	22.10	6.45	4.91	3.07	2.15	0.92	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	43.10	18.78	7.25	5.55	1.28	1.71	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	37.91	23.66	5.16	5.46	2.43	2.73	0.91	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	26.72	19.02	7.46	5.54	3.13	2.17	1.93	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	37.20	21.38	6.68	10.25	6.68	1.78	2.67	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	28.69	19.01	9.67	8.34	3.67	2.00	3.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	24.16	20.44	7.43	11.15	3.72	1.86	5.57	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	18.08	8.29	3.77	2.64	6.78	1.88	2.26	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	22.68	18.75	6.54	10.03	4.80	3.93	3.05	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	46.86	29.99	13.12	15.00	9.37	15.00	3.75	1.87
adenocarcinoma cell line:IM95m	10796-110I4	74.89	25.20	8.95	6.12	0.94	0.24	1.65	0.94
adipose tissue, adult, pool1	10010-101C1	67.79	75.23	7.14	4.65	4.96	1.71	1.71	1.40
adipose, donor1	10184-103D4	71.54	53.36	11.73	8.80	4.69	1.76	2.35	0.59
adipose, donor2	10185-103D5	26.36	17.44	2.43	1.22	0.41	1.62	0.41	0.00
adipose, donor3	10186-103D6	29.13	17.43	4.90	3.00	0.00	0.82	0.82	0.27
adipose, donor4	10187-103D7	63.27	16.47	4.33	4.33	3.47	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	42.61	26.04	20.67	24.94	3.16	2.37	4.42	0.32
adrenal gland, adult, pool1	10081-102A9	43.65	32.74	3.64	0.00	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	60.83	33.75	7.87	13.87	3.07	2.00	4.14	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	33.59	65.39	2.50	4.64	1.43	1.07	0.36	1.07
amniotic membrane cells, donor1	12235-129G3	112.91	124.97	6.72	7.42	5.56	2.78	1.16	1.39
amniotic membrane cells, donor2	12236-129G4	45.98	31.11	4.73	3.38	2.03	0.68	1.35	0.68
amniotic membrane cells, donor3	12237-129G5	149.66	152.60	11.78	12.96	5.30	2.06	0.88	0.88
amygdala - adult, donor10196	10167-103B5	60.48	41.50	9.49	8.30	0.00	1.19	0.00	1.19
amygdala, adult, donor10252	10151-102I7	94.08	76.24	9.73	5.07	1.42	0.41	0.41	1.42
amygdala, newborn, donor10223	10360-105E9	26.14	33.57	4.20	4.52	0.65	0.00	0.97	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	43.16	46.35	7.64	12.22	4.33	1.78	4.58	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	40.82	31.33	7.28	7.50	2.21	0.44	1.10	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	36.74	37.75	7.35	7.35	2.00	0.67	1.67	0.67
aorta, adult, pool1	10052-101G7	92.77	149.85	6.67	5.88	7.06	3.92	1.77	1.18
appendix, adult	10189-103D9	47.74	68.31	5.82	6.99	1.94	2.33	2.33	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	40.93	55.03	6.19	6.19	3.44	2.06	0.34	0.34
artery, adult	10190-103E1	133.15	161.68	9.51	17.66	6.79	5.43	1.36	4.08
astrocytoma cell line:TM-31	10425-106D2	49.83	58.24	12.02	7.97	13.04	9.85	2.75	0.87
b cell line:RPMI1788	10427-106D4	38.66	24.54	8.62	7.44	1.78	2.53	4.31	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	16.65	27.74	3.61	1.39	0.28	0.28	0.55	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	34.93	21.24	6.55	8.34	3.77	2.68	3.18	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	59.42	52.22	4.18	5.52	1.51	1.67	0.33	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	27.40	8.95	3.36	5.59	3.36	0.00	1.12	1.12
bladder, adult, pool1	10011-101C2	188.28	187.51	11.19	12.39	5.32	3.26	2.50	1.96
blood, adult, pool1	10053-101G8	124.02	44.29	4.43	4.43	0.00	2.21	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	16.27	9.42	1.71	1.71	2.57	0.86	0.00	0.00
bone marrow, adult	10192-103E3	21.59	75.58	4.72	4.05	7.42	5.40	3.37	1.35
brain, adult, donor1	10084-102B3	69.70	43.05	8.20	6.15	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	98.77	50.78	14.59	9.13	1.67	1.00	0.78	0.89
brain, fetal, pool1	10085-102B4	56.10	50.76	8.01	13.36	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	51.54	31.38	11.23	9.25	2.31	4.96	1.98	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	76.39	31.08	6.49	5.99	1.00	0.75	1.87	0.62
breast, adult, donor1	10080-102A8	56.19	71.97	3.16	3.16	5.05	1.26	2.53	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	39.51	20.07	3.30	2.79	2.29	1.78	1.27	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	89.67	53.19	7.11	9.28	1.24	2.47	2.16	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	24.17	65.84	2.30	1.38	1.38	0.00	0.46	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	45.27	32.20	5.08	4.60	0.97	0.73	0.97	0.97
carcinoid cell line:NCI-H1770	10703-109H1	39.02	23.04	7.99	9.87	0.00	0.00	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	79.96	52.61	10.61	14.55	17.61	12.69	6.34	0.77
carcinoid cell line:SK-PN-DW	10719-109I8	16.48	20.28	6.65	2.85	0.00	0.32	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	22.63	41.52	2.66	4.79	0.80	0.80	1.33	0.27
caudate nucleus - adult, donor10196	10177-103C6	79.44	52.96	14.97	6.91	2.30	0.00	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	134.36	62.75	12.72	7.36	0.84	2.84	1.84	1.67
caudate nucleus, adult, donor10258	10379-105H1	97.05	29.04	13.75	8.41	0.76	0.76	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	41.38	46.51	5.49	6.59	1.83	1.83	0.37	1.10
cerebellum - adult, donor10196	10173-103C2	101.96	34.96	11.65	11.65	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	76.22	56.37	12.38	10.89	0.43	1.07	1.28	0.21
cerebellum, adult, pool1	10083-102B2	46.91	28.29	8.97	5.52	0.00	0.00	1.03	0.00
cerebellum, newborn, donor10223	10357-105E6	46.50	82.20	4.98	10.79	1.66	0.83	1.66	0.00
cerebral meninges, adult	10188-103D8	60.77	45.39	12.86	8.32	3.28	2.27	0.76	0.76
cerebrospinal fluid, donor2	10294-104G6	33.62	36.54	8.04	8.77	2.19	0.00	2.92	0.00
cervical cancer cell line:D98-AH2	10552-107I3	84.98	58.52	6.76	5.03	0.43	1.44	1.58	1.29
cervical cancer cell line:ME-180	10553-107I4	103.41	56.84	6.79	11.10	4.97	4.31	3.15	0.66
cervix, adult, pool1	10013-101C4	107.30	152.87	8.61	7.87	6.51	3.88	2.10	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	31.77	37.76	5.02	3.48	4.60	2.09	1.53	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	36.58	27.43	7.84	6.53	1.31	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	102.03	42.25	10.94	12.55	5.34	4.72	4.60	1.12
choriocarcinoma cell line:SCH	10785-110H2	69.12	49.65	7.15	4.68	4.07	3.08	1.97	1.36
choriocarcinoma cell line:T3M-3	10618-108G6	132.11	30.60	12.33	18.50	4.98	4.74	5.69	1.90
chorionic membrane cells, donor1	12238-129G6	49.01	58.41	8.55	8.83	1.71	1.14	0.85	0.28
chorionic membrane cells, donor2	12239-129G7	23.66	28.34	5.17	2.78	0.70	0.70	0.40	0.20
chorionic membrane cells, donor3	12240-129G8	40.66	30.22	6.59	11.54	1.65	2.20	3.85	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	5.05	0.00	6.06	1.01	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	40.92	19.02	4.99	4.23	3.07	1.34	2.50	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	36.54	14.57	6.76	4.86	2.11	1.69	1.06	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	24.91	25.94	3.85	4.37	0.51	0.26	0.77	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	30.23	29.99	2.42	2.42	0.73	0.48	1.21	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	26.88	26.47	3.87	2.65	0.20	0.41	0.61	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	27.97	27.38	1.77	2.36	0.00	0.59	0.29	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	51.60	27.11	8.86	4.17	1.04	1.82	3.91	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	31.32	41.37	2.74	2.29	1.60	0.91	0.46	0.69
clear cell carcinoma cell line:TEN	10636-108I6	43.20	47.37	6.25	6.42	2.95	2.78	1.04	1.04
colon carcinoma cell line:CACO-2	10513-107D9	59.31	28.01	4.94	6.41	2.56	2.38	1.10	1.10
colon carcinoma cell line:COLO-320	10420-106C6	91.60	58.15	10.64	13.68	0.76	1.14	5.32	0.76
colon, adult, donor1	10082-102B1	105.91	72.59	4.76	3.57	2.38	2.38	1.19	1.19
colon, adult, pool1	10014-101C5	150.29	88.95	6.70	7.64	3.41	2.35	2.00	1.88
colon, fetal, donor1	10070-101I7	66.12	103.20	6.18	5.56	4.94	1.85	2.47	3.09
common myeloid progenitor CMP, donor1	12130-128D6	151.26	100.84	13.75	45.84	96.25	27.50	32.08	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	16.57	27.62	2.55	8.50	2.97	0.85	1.27	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.38	38.19	3.02	3.77	2.26	1.66	0.60	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	23.55	35.53	2.96	4.79	3.53	1.27	1.41	0.42
corpus callosum, adult, pool1	10042-101F6	94.75	75.85	10.50	11.17	3.54	2.10	2.21	0.88
cruciate ligament, donor2	10295-104G7	34.04	61.60	4.05	10.54	4.05	1.62	2.43	0.81
diaphragm, fetal, donor1	10069-101I6	85.87	88.28	8.83	7.22	2.41	1.61	1.61	0.00
diencephalon, adult	10193-103E4	45.60	37.20	8.64	8.88	1.44	0.72	0.72	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	34.44	15.38	6.89	7.35	1.38	2.07	2.07	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	87.45	33.85	9.74	15.39	3.59	4.10	1.54	2.05
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	26.48	36.11	7.46	3.85	0.96	0.72	0.96	0.48
ductus deferens, adult	10196-103E7	64.29	85.22	5.98	4.98	2.49	1.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	56.17	67.69	7.20	4.32	0.00	0.00	4.32	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	59.59	67.68	8.09	8.83	1.47	1.47	2.21	2.21
dura mater, adult, donor1	10041-101F5	69.62	50.05	7.35	7.19	11.07	6.69	2.81	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	8.44	8.66	4.22	6.22	1.33	2.44	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	6.30	8.17	1.86	3.01	1.43	0.29	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	28.98	38.23	9.25	11.72	1.23	0.00	3.70	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	18.77	32.39	4.24	6.05	0.30	0.91	1.21	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	29.33	48.16	4.94	5.56	1.54	0.62	1.54	0.31
embryonic pancreas cell line:2C6	10603-108E9	28.90	28.90	5.25	7.88	2.63	0.00	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	62.01	46.59	6.37	10.73	0.34	1.34	2.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	28.27	38.06	5.07	5.98	1.45	0.00	0.72	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	31.36	35.38	6.59	4.66	1.29	1.29	0.32	0.48
epidermoid carcinoma cell line:A431	10426-106D3	68.92	27.90	7.11	8.11	6.11	4.45	3.22	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	70.61	32.45	11.66	13.86	8.25	7.37	4.51	0.99
epididymis, adult	10197-103E8	39.14	64.05	5.44	10.26	3.77	1.47	2.51	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	34.59	37.08	3.19	3.73	2.31	0.89	0.89	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.19	21.63	2.36	1.18	0.00	0.39	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	61.07	69.33	5.50	7.21	4.19	3.28	3.01	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	62.00	66.43	5.71	7.58	4.92	3.74	3.35	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	63.52	69.79	7.51	7.28	5.15	3.92	2.58	0.56
esophagus, adult, pool1	10015-101C6	227.33	162.13	12.42	9.24	7.22	4.57	2.97	3.08
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	25.55	49.97	3.38	2.88	1.38	0.75	0.75	0.50
eye - muscle inferior rectus, donor1	10272-104E2	36.22	67.61	12.07	14.49	2.41	7.24	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	25.25	0.00	12.63	2.10	2.10	4.21	0.00
eye - muscle medial, donor2	10299-104H2	34.23	37.21	8.93	17.86	7.44	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	19.49	36.69	4.59	9.17	5.73	2.29	5.73	2.29
eye - vitreous humor, donor1	10268-104D7	14.57	14.57	7.29	8.74	8.74	5.83	5.83	0.00
eye, fetal, donor1	10054-101G9	89.49	61.02	6.36	6.36	2.80	1.02	1.53	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	22.57	13.08	6.28	3.85	1.28	0.90	1.54	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	34.19	40.36	4.27	2.37	2.37	1.66	2.85	0.47
frontal lobe, adult, pool1	10040-101F4	138.20	57.70	16.89	9.48	2.06	0.75	0.84	1.31
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	210.47	98.48	14.11	15.91	12.91	9.61	8.71	2.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	42.15	59.16	8.60	10.06	2.19	2.65	2.10	0.55
gall bladder, adult	10198-103E9	65.19	74.12	8.45	7.24	4.35	2.17	1.93	1.69
gamma delta positive T cells, donor1	11937-126A2	27.92	21.47	4.83	6.44	1.07	0.54	2.15	0.54
gamma delta positive T cells, donor2	11938-126A3	26.89	25.40	4.48	7.10	1.49	1.12	1.87	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	37.39	36.96	4.22	3.17	1.69	1.27	0.63	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	33.27	25.92	3.29	3.09	0.39	0.39	0.77	1.16
gastric cancer cell line:AZ521	10549-107H9	35.58	46.24	5.41	5.90	1.48	0.98	0.82	0.82
gastric cancer cell line:GSS	10560-108A2	18.30	9.15	6.41	10.07	1.83	4.58	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	62.37	22.16	6.17	5.71	2.28	2.51	0.91	0.46
giant cell carcinoma cell line:LU65	10487-107B1	21.69	18.24	2.41	1.84	0.46	0.57	0.57	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	31.91	25.47	5.04	4.48	2.24	1.96	0.98	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	80.06	37.91	4.99	10.72	3.74	3.74	3.24	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	29.77	34.83	5.28	4.22	1.27	0.84	0.84	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	43.68	36.65	4.63	3.51	1.54	0.84	1.40	0.98
glioblastoma cell line:T98G	10485-107A8	40.51	21.08	3.53	5.96	2.21	1.88	1.43	0.55
glioma cell line:GI-1	10413-106B8	36.02	21.67	5.56	4.69	1.46	0.88	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	72.16	54.67	9.48	5.10	0.73	0.73	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	100.81	123.02	10.25	8.79	3.42	1.22	1.71	1.22
globus pallidus, adult, donor10258	10367-105F7	45.18	49.29	5.48	2.74	1.37	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	29.84	23.45	1.60	6.40	1.60	0.53	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	117.46	129.70	29.37	51.39	53.84	22.02	34.26	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	10.93	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	5.23	0.00	0.00	10.45	5.23	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	32.64	39.04	3.52	3.20	1.92	0.32	1.28	0.00
hIPS +CCl2, biol_rep1	14383-156B9	35.35	23.87	8.72	8.72	2.30	1.84	2.75	0.00
hIPS +CCl2, biol_rep2	14384-156C1	34.29	12.35	9.15	7.77	1.83	4.57	4.12	0.00
hIPS +CCl2, biol_rep3	14385-156C2	30.92	14.17	7.09	9.02	1.93	1.29	3.22	0.64
hIPS, biol_rep1	14380-156B6	17.25	4.31	5.75	5.75	1.44	0.00	4.31	0.00
hIPS, biol_rep2	14381-156B7	29.49	8.23	6.17	4.80	2.74	4.12	2.74	0.69
hIPS, biol_rep3	14382-156B8	65.10	24.28	8.83	15.45	1.10	2.21	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	36.78	29.31	7.18	7.47	4.02	2.30	1.44	0.86
heart - mitral valve, adult	10205-103F7	53.81	108.23	5.08	8.67	6.88	1.20	0.30	1.79
heart - pulmonic valve, adult	10206-103F8	66.94	124.72	6.01	8.89	4.18	1.05	2.09	0.78
heart - tricuspid valve, adult	10207-103F9	47.46	126.56	3.33	7.49	8.33	0.83	2.50	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	59.38	69.58	7.75	6.12	3.06	1.22	0.82	0.61
heart, adult, diseased, donor1	10051-101G6	79.20	90.70	5.96	12.35	1.28	0.85	0.00	2.13
heart, adult, pool1	10016-101C7	175.47	181.91	11.73	12.65	7.36	2.76	2.53	1.15
heart, fetal, pool1	10046-101G1	122.91	111.51	11.50	14.17	3.90	3.49	1.64	1.33
hepatic mesenchymal tumor cell line:LI90	10778-110G4	52.14	17.28	5.86	5.55	0.62	1.23	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	35.68	20.22	4.76	4.76	1.19	2.38	5.95	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	62.87	55.91	6.52	4.53	0.55	0.55	0.55	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	66.88	61.90	6.68	5.22	0.97	0.61	0.61	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	64.88	60.94	5.86	5.05	0.71	0.71	0.61	1.41
hepatoma cell line:Li-7	10484-107A7	20.91	31.14	2.22	2.34	1.22	0.56	0.56	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	54.67	12.96	11.66	11.16	2.31	2.31	2.61	0.80
hippocampus - adult, donor10196	10169-103B7	89.90	37.85	13.25	7.57	2.84	1.89	0.95	1.89
hippocampus, adult, donor10252	10153-102I9	85.31	80.21	8.78	7.76	2.45	1.22	0.00	0.41
hippocampus, adult, donor10258	10374-105G5	55.27	16.93	11.95	5.98	0.50	1.00	0.00	1.99
hippocampus, newborn, donor10223	10363-105F3	32.43	35.95	1.76	3.52	1.41	0.70	0.35	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	47.00	48.83	14.04	6.10	4.88	2.44	3.66	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	28.08	28.86	4.32	4.12	2.16	2.16	1.37	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	19.80	23.87	3.05	5.59	2.54	1.78	1.78	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	21.99	21.43	3.95	2.82	1.69	2.26	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	37.44	30.73	3.10	2.58	0.77	1.03	0.52	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	30.37	22.02	2.66	5.69	2.28	2.28	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	21.02	17.23	3.21	1.17	0.29	0.88	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	29.51	21.76	1.08	3.45	0.86	1.08	1.51	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.44	16.27	1.67	3.75	0.83	0.00	1.25	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	23.44	16.34	4.03	5.21	1.89	2.37	1.66	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	25.07	21.70	4.18	3.05	1.93	2.09	1.93	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	19.53	10.77	3.37	4.71	0.67	2.69	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	28.32	23.94	4.38	4.38	1.10	1.56	0.94	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	30.95	25.55	5.40	4.42	1.47	1.47	1.47	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	19.20	25.31	3.49	2.62	0.87	0.87	4.36	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	34.17	36.85	3.25	3.25	0.38	0.95	0.57	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	31.40	29.22	2.62	2.62	2.18	1.31	1.74	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	36.98	30.49	4.00	3.00	1.50	2.50	2.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	20.72	20.35	2.07	3.01	0.38	0.38	0.75	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	20.92	21.37	0.45	4.55	0.45	2.27	0.00	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	19.11	16.60	1.88	1.88	0.94	1.25	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.88	18.94	3.76	2.78	1.80	2.61	1.14	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	20.90	20.61	2.32	2.32	2.32	2.03	1.16	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.33	20.03	3.59	3.59	1.20	1.79	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	31.41	28.45	4.25	4.80	1.29	2.40	2.40	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	30.24	24.53	5.14	3.99	0.29	1.14	0.57	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	35.52	40.83	6.94	8.57	2.45	0.82	1.63	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	27.11	33.45	3.52	4.22	1.76	1.06	1.06	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	28.51	22.81	0.95	2.85	1.90	1.90	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.33	25.12	1.82	1.82	1.21	2.12	0.61	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	24.82	20.68	3.62	4.14	0.52	1.03	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	22.58	12.62	1.33	3.98	2.66	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	12.31	15.14	2.82	1.80	1.80	1.80	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.45	19.17	4.09	2.81	1.02	1.02	1.02	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	13.63	14.39	3.03	0.76	2.27	3.03	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	15.79	23.19	1.34	2.35	1.68	1.68	1.68	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	29.22	24.15	4.59	4.83	0.97	1.69	1.45	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	27.19	32.98	4.46	5.79	0.89	0.89	2.67	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	25.85	22.44	4.39	7.32	0.98	2.93	0.98	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	28.12	23.84	1.22	2.14	0.92	0.92	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	107.36	165.92	22.77	9.76	3.25	9.76	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	26.48	29.78	2.32	5.63	0.66	3.31	1.65	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	29.55	14.78	2.19	1.09	1.64	1.09	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	21.71	22.07	2.17	4.70	1.09	1.45	2.17	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	17.79	15.66	1.78	3.56	1.07	1.42	1.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	21.48	13.13	2.39	0.00	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	36.70	25.46	4.06	4.20	2.57	2.57	1.49	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	15.62	15.62	3.23	1.89	1.89	1.08	1.35	0.81
immature langerhans cells, donor1	11904-125F5	11.62	14.53	9.69	28.57	15.98	13.32	9.44	0.24
immature langerhans cells, donor2	11905-125F6	7.92	3.96	4.75	6.34	3.17	1.58	2.38	0.00
insula, adult, pool1	10039-101F3	135.33	50.82	16.84	7.67	1.04	0.47	0.85	1.23
keratoacanthoma cell line:HKA-1	10791-110H8	58.85	35.12	3.90	5.20	1.95	2.93	1.63	0.65
kidney, adult, pool1	10017-101C8	59.18	79.20	7.31	6.01	5.31	3.10	2.80	1.00
kidney, fetal, pool1	10045-101F9	58.36	45.34	5.09	6.37	3.11	1.91	1.34	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	25.85	37.78	3.83	3.98	0.85	0.71	1.42	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	9.68	23.64	1.11	2.21	0.28	0.41	0.41	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	33.40	37.07	5.50	8.26	6.42	3.30	2.94	0.73
left atrium, adult, donor1	10079-102A7	72.47	67.56	3.81	5.45	0.54	1.63	0.00	0.54
left ventricle, adult, donor1	10078-102A6	61.69	84.95	3.54	9.10	2.02	1.01	2.02	0.51
leiomyoblastoma cell line:G-402	10721-110A1	34.20	52.53	6.02	3.56	0.82	0.82	0.82	0.82
leiomyoma cell line:10964C	10569-108B2	8.98	17.96	0.36	1.08	0.72	0.36	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	10.87	9.24	0.00	0.54	0.00	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	14.81	25.50	2.43	2.43	0.49	0.00	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	20.91	5.23	1.05	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	34.71	17.12	5.67	3.66	3.07	1.42	1.30	0.59
liposarcoma cell line:KMLS-1	10782-110G8	46.55	24.21	3.91	2.50	0.94	0.31	0.31	0.47
liposarcoma cell line:SW 872	10726-110A6	29.85	16.08	4.87	5.73	1.34	1.22	1.34	0.49
liver, adult, pool1	10018-101C9	42.14	37.92	3.89	5.02	0.65	0.32	0.65	0.65
liver, fetal, pool1	10086-102B5	31.04	31.98	2.82	0.94	0.00	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	41.85	46.52	9.62	6.27	1.75	1.02	1.17	0.29
locus coeruleus, adult, donor10252	10165-103B3	72.34	64.22	12.00	6.09	1.29	0.74	0.92	0.55
locus coeruleus, adult, donor10258	10375-105G6	34.42	28.50	11.57	6.77	0.28	0.28	0.56	0.28
locus coeruleus, newborn, donor10223	10362-105F2	37.01	55.52	5.89	4.63	0.42	0.00	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	59.09	69.75	6.92	5.81	3.04	1.38	1.94	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	39.30	21.37	10.34	14.48	9.65	6.20	8.96	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	54.31	59.98	5.80	6.06	2.64	1.98	1.45	0.66
lung, adult, pool1	10019-101D1	70.88	104.42	5.55	6.50	7.56	2.95	2.01	1.42
lung, fetal, donor1	10068-101I5	121.30	124.44	11.70	15.98	15.98	4.57	4.85	1.14
lung, right lower lobe, adult, donor1	10075-102A3	57.28	76.52	3.21	6.42	3.67	1.83	3.67	1.83
lymph node, adult, donor1	10077-102A5	56.33	45.92	6.15	4.26	3.79	1.42	1.89	0.47
lymphangiectasia cell line:DS-1	10727-110A7	43.62	15.78	14.03	7.23	1.10	3.07	1.53	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.75	16.45	6.49	9.81	0.75	1.51	1.66	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	85.80	58.62	8.49	9.34	1.70	3.40	1.70	0.85
mature adipocyte, donor1	12231-129F8	41.29	47.51	12.43	8.44	1.33	1.78	0.89	0.00
mature adipocyte, donor2	12232-129F9	40.88	50.01	9.75	6.43	1.04	0.62	0.21	1.04
mature adipocyte, donor3	12233-129G1	36.51	45.52	6.40	7.59	4.03	0.24	1.90	1.42
mature adipocyte, donor4	12234-129G2	30.01	42.64	8.69	10.00	2.11	0.79	0.53	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	139.62	85.30	17.15	22.87	3.81	5.24	4.29	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	94.75	41.74	11.28	6.77	1.13	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	89.75	68.60	9.01	5.33	1.10	0.55	0.92	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	63.22	30.18	13.66	4.77	0.95	1.91	0.64	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	59.28	67.39	9.81	3.41	1.71	0.00	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	69.53	65.64	10.97	5.74	0.51	1.18	0.84	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	95.08	77.89	13.16	5.52	1.27	1.06	0.42	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	50.08	30.82	9.63	11.56	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	229.66	172.24	43.06	0.00	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	43.43	53.48	3.95	2.15	0.72	0.00	0.72	1.44
medulla oblongata - adult, donor10196	10174-103C3	66.84	51.92	14.28	9.73	3.24	3.24	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	75.39	69.66	8.67	7.89	2.79	1.08	0.62	0.77
medulla oblongata, adult, pool1	10038-101F2	82.53	48.57	12.16	11.43	2.61	1.63	2.53	1.06
medulla oblongata, newborn, donor10223	10361-105F1	38.19	48.61	3.12	5.55	2.08	1.04	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	27.68	32.77	2.44	1.55	0.89	1.77	1.33	0.66
medulloblastoma cell line:ONS-76	10759-110E3	41.57	10.64	4.04	4.40	1.59	1.35	1.35	0.73
melanoma cell line:COLO 679	10514-107E1	39.53	24.87	5.89	5.32	1.15	1.44	2.59	0.00
melanoma cell line:G-361	10465-106H6	37.46	28.23	5.16	4.61	1.63	1.63	0.81	0.54
meningioma cell line:HKBMM	10691-109F7	16.28	28.22	2.17	2.89	0.36	1.27	0.36	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.91	47.58	2.64	7.93	0.88	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	29.81	21.26	7.26	6.74	0.26	1.56	1.81	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.76	38.82	3.38	2.30	0.31	0.77	0.46	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	30.54	26.36	3.64	1.64	1.09	0.18	0.00	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.88	21.95	0.83	0.83	1.24	0.41	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.47	29.22	3.23	1.69	0.14	0.14	0.14	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	30.81	30.81	3.08	2.31	0.00	0.19	0.58	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.11	25.68	2.78	0.00	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	24.89	24.03	3.43	1.54	0.17	0.17	0.00	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	28.98	26.34	2.53	1.15	0.46	0.12	0.23	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	29.45	24.67	2.65	1.72	0.40	0.66	0.27	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.95	28.90	4.05	2.03	1.08	0.27	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	34.43	44.67	2.70	1.71	1.00	0.28	0.14	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	22.07	33.26	2.31	0.66	0.66	0.33	0.33	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	40.68	40.54	4.01	1.52	1.52	0.55	0.83	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.20	32.81	2.44	0.70	1.40	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	37.36	24.09	2.04	2.04	0.20	0.00	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.78	22.29	1.08	2.16	1.80	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	28.14	26.79	3.72	1.55	0.41	0.10	0.31	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	11.86	23.03	1.14	0.68	0.46	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	40.28	39.02	4.62	2.52	1.26	0.84	1.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	41.54	47.07	2.99	2.09	0.30	0.00	0.15	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	32.82	44.55	2.10	1.66	0.70	0.18	0.09	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.99	25.03	2.58	0.37	0.74	0.00	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.59	22.32	1.72	0.86	0.00	0.29	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	18.52	28.21	4.21	2.11	4.21	1.68	1.68	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.55	12.33	5.02	0.91	0.91	0.91	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	22.76	19.95	3.58	4.09	0.77	0.51	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	24.61	20.16	2.88	2.09	0.52	0.26	0.26	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	23.41	17.87	2.77	1.23	0.92	0.92	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.01	16.47	3.06	2.12	0.24	1.65	0.47	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	26.06	20.31	5.08	4.06	1.69	0.34	0.34	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	18.08	23.97	2.75	2.75	1.57	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.24	31.05	1.39	1.85	0.93	0.93	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	29.13	27.40	4.33	3.75	1.15	1.15	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	30.34	21.86	3.57	2.90	1.12	2.01	0.22	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	26.44	22.11	5.53	1.92	0.96	0.48	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	33.73	42.53	2.20	6.60	1.47	1.47	2.20	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.81	17.12	3.36	2.01	1.68	0.67	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.97	24.56	1.64	2.05	0.41	0.41	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	23.20	24.48	4.30	2.15	1.29	0.43	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	5.47	0.00	2.73	2.73	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	25.82	15.49	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.97	17.86	2.92	2.60	1.30	0.00	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	16.00	2.91	4.36	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.72	12.79	3.20	1.60	0.53	1.07	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	15.54	14.72	5.72	4.91	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.99	19.05	4.66	2.72	3.50	1.55	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	16.79	4.20	2.10	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	9.93	20.86	3.97	0.99	1.99	0.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	14.30	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.05	20.16	3.56	1.19	1.19	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	15.84	4.87	4.87	4.87	1.22	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.13	12.67	1.90	1.90	0.63	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	11.04	35.18	2.41	1.72	2.41	0.34	0.34	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	47.28	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	59.88	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	34.44	3.44	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	10.59	31.38	0.81	0.41	2.44	0.81	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	34.16	2.38	0.00	1.59	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.02	22.99	1.18	0.00	2.36	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.47	29.61	1.25	0.62	1.25	2.49	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	36.09	0.00	0.00	1.34	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	13.01	1.18	3.55	3.55	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	23.11	0.00	2.57	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.14	22.72	3.44	2.07	0.00	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	12.86	14.84	1.98	2.47	0.99	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	15.70	2.24	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.00	13.36	3.18	2.54	0.00	0.00	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.10	13.30	2.82	2.42	0.81	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	8.72	6.54	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	6.34	1.27	2.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	25.49	29.74	4.86	4.25	0.00	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	22.59	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	18.12	4.12	4.12	0.00	0.00	0.00	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.52	12.30	1.79	1.98	0.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.76	13.30	1.62	0.32	0.00	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	8.15	11.20	1.02	0.00	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	5.42	10.83	3.87	2.32	0.77	0.77	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	59.06	66.86	8.50	11.34	0.71	2.13	1.65	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	30.58	43.79	2.78	1.62	0.93	1.62	0.93	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	34.19	0.00	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	20.65	18.60	3.39	1.75	1.13	0.72	0.31	0.10
mesothelioma cell line:Mero-25	10850-111F4	7.94	9.08	0.45	2.27	0.68	0.68	0.68	0.00
mesothelioma cell line:Mero-41	10851-111F5	21.02	24.69	3.18	4.16	0.73	1.22	0.24	0.98
mesothelioma cell line:Mero-48a	10852-111F6	26.79	24.14	2.44	2.21	0.22	0.66	0.00	1.11
mesothelioma cell line:Mero-82	10853-111F7	21.02	22.34	3.15	2.37	0.53	0.53	0.79	0.53
mesothelioma cell line:Mero-83	10854-111F8	27.58	24.34	4.43	3.74	1.02	1.02	0.85	1.02
mesothelioma cell line:Mero-84	10855-111F9	7.84	6.82	3.54	2.53	1.77	0.51	1.26	0.00
mesothelioma cell line:Mero-95	10856-111G1	27.95	18.84	2.48	1.45	1.04	1.04	0.21	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	38.10	32.30	3.31	5.30	2.65	2.48	0.83	0.33
mesothelioma cell line:NCI-H226	10846-111E9	13.76	14.48	1.99	1.09	0.36	0.36	0.36	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	26.48	25.45	2.22	2.39	1.02	1.02	1.02	0.17
mesothelioma cell line:NCI-H28	10845-111E8	25.19	28.50	3.31	3.05	2.80	2.29	1.02	0.25
mesothelioma cell line:No36	10857-111G2	16.31	14.68	2.94	7.18	0.33	0.65	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	12.46	10.84	1.63	1.08	0.27	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	28.21	12.67	4.61	5.37	1.92	0.77	1.73	1.15
migratory langerhans cells, donor2	11902-125F3	29.80	15.02	2.93	3.18	1.47	1.34	0.85	0.49
migratory langerhans cells, donor3	11903-125F4	34.64	8.79	6.46	2.51	0.90	1.08	1.79	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	13.71	31.02	2.61	4.24	0.33	0.98	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	36.88	44.72	5.72	3.18	1.27	0.64	1.06	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	49.30	22.58	10.60	10.37	2.53	3.46	3.92	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	33.49	23.41	4.57	3.23	0.00	1.14	1.90	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	31.78	22.36	9.42	10.53	3.88	1.29	2.96	0.18
myeloma cell line:PCM6	10474-106I6	14.63	12.45	6.33	5.34	0.79	0.00	0.40	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	19.78	24.86	3.55	8.12	3.04	4.57	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	32.56	16.48	4.51	1.57	0.78	0.98	0.20	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	48.92	26.63	10.25	5.79	0.89	1.45	0.56	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	44.27	30.52	8.02	8.38	1.54	1.10	0.66	0.29
nasal epithelial cells, donor2	12227-129F4	62.37	40.85	8.83	7.73	1.66	2.76	2.21	1.10
neuroblastoma cell line:CHP-134	10508-107D4	47.85	41.87	5.06	6.90	0.00	0.23	0.46	0.69
neuroblastoma cell line:NB-1	10539-107G8	60.24	58.00	9.73	8.79	2.06	2.81	1.87	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	46.61	17.71	5.48	7.38	1.48	2.32	0.84	0.21
neuroblastoma cell line:NH-12	10555-107I6	75.66	44.17	6.52	10.44	1.68	1.49	2.05	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	21.35	37.01	2.85	1.19	0.47	0.00	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	24.55	36.11	3.33	1.74	0.16	0.16	0.32	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	11.07	7.45	4.63	3.22	0.40	0.40	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	37.51	27.34	1.27	3.81	0.64	0.64	0.64	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	45.78	22.62	4.79	2.93	0.80	0.27	0.27	0.80
neutrophil PMN, donor1	12133-128D9	29.75	29.75	29.75	44.62	208.25	44.62	29.75	0.00
neutrophil PMN, donor2	12137-128E4	53.12	13.28	13.28	26.56	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	18.94	0.00	0.00	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	79.99	51.75	5.41	9.98	4.40	3.89	2.88	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.02	32.02	9.61	6.40	1.60	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	17.63	15.07	1.92	1.92	0.64	0.00	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	7.62	19.18	1.58	0.53	0.79	1.05	1.58	0.00
nucleus accumbens, adult, pool1	10037-101F1	131.42	45.46	16.40	9.47	1.87	1.03	0.94	1.41
occipital cortex - adult, donor10196	10172-103C1	90.66	41.21	10.30	10.30	2.06	2.06	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	100.64	84.80	11.00	8.32	1.34	1.88	0.54	1.34
occipital cortex, newborn, donor10223	10355-105E4	47.68	56.41	2.91	2.91	1.46	1.09	0.73	1.46
occipital lobe, adult, donor1	10076-102A4	106.53	70.06	9.97	5.77	1.05	1.05	0.79	1.05
occipital lobe, fetal, donor1	10073-102A1	81.96	69.94	7.29	3.86	0.43	1.29	0.86	1.72
occipital pole, adult, pool1	10036-101E9	82.47	29.96	7.81	5.36	0.87	0.55	0.63	1.10
olfactory region, adult	10195-103E6	85.78	52.16	11.46	6.50	0.57	1.91	1.34	0.96
optic nerve, donor1	10277-104E7	36.02	58.03	6.00	8.00	10.01	0.00	8.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	74.15	52.63	6.15	4.78	1.94	2.05	2.05	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	47.95	18.41	8.38	13.05	2.20	1.10	3.98	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.26	26.08	2.88	3.56	1.02	0.51	1.02	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	43.66	31.65	3.70	4.27	1.04	1.73	1.50	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	19.70	14.40	4.70	3.82	1.18	1.76	1.47	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	45.78	20.56	4.67	6.54	5.61	4.67	3.74	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	46.87	40.08	4.67	5.30	4.03	3.82	1.06	1.91
ovary, adult, pool1	10020-101D2	78.27	65.25	10.92	12.84	6.38	3.32	2.27	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	61.60	28.78	8.98	6.42	1.65	2.93	1.47	0.92
pancreas, adult, donor1	10049-101G4	52.68	23.52	4.70	7.53	0.00	0.94	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	62.90	37.18	4.19	5.03	3.91	3.35	1.68	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	13.12	19.59	3.58	2.90	1.36	1.19	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	41.73	42.72	4.97	6.46	2.15	1.16	1.49	0.66
paracentral gyrus, adult, pool1	10035-101E8	134.17	44.30	17.21	9.88	1.37	1.19	1.56	1.37
parietal cortex, adult, donor10258	10373-105G4	67.53	19.82	16.88	7.34	2.20	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	92.17	43.26	15.05	7.52	3.76	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	108.03	65.84	14.54	5.99	2.28	1.43	0.86	1.14
parietal lobe, adult, pool1	10034-101E7	120.28	39.92	14.36	9.52	1.41	0.53	1.06	1.06
parietal lobe, fetal, donor1	10072-101I9	59.16	64.98	7.76	0.97	0.00	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	37.01	56.45	6.73	4.86	0.37	0.00	0.37	1.50
parotid gland, adult	10199-103F1	70.92	57.35	9.87	9.87	2.47	1.23	2.47	1.85
penis, adult	10200-103F2	85.40	104.74	5.91	9.67	4.30	1.07	2.15	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	17.85	31.98	5.39	9.30	0.19	0.74	0.74	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	29.14	19.23	3.50	3.64	2.04	2.04	1.75	0.58
pineal gland - adult, donor10196	10179-103C8	86.43	35.48	12.26	7.10	1.94	1.29	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	191.88	90.02	20.14	11.25	4.74	2.96	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	74.62	52.67	17.56	13.17	1.25	1.88	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	74.87	88.03	13.15	8.09	2.02	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	160.00	119.35	23.97	20.85	6.25	3.65	2.61	1.56
pituitary gland, adult, donor10258	10378-105G9	40.01	38.31	5.96	6.81	0.85	1.70	2.55	0.85
placenta, adult, pool1	10021-101D3	135.99	84.07	7.74	5.81	3.33	1.72	2.26	2.26
plasma cell leukemia cell line:ARH-77	10840-111E3	22.64	23.04	5.56	6.89	1.32	2.25	2.12	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	30.35	23.03	3.89	2.80	1.09	0.78	0.47	0.16
pons, adult, pool1	10033-101E6	82.62	38.39	15.23	8.95	1.72	0.95	0.77	0.43
postcentral gyrus, adult, pool1	10032-101E5	99.90	41.50	12.81	8.98	1.22	0.96	0.70	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	46.01	52.28	20.91	37.65	23.01	14.64	31.37	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	11.02	5.51	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	41.66	43.70	5.24	4.66	1.75	1.02	1.46	1.31
prostate cancer cell line:PC-3	10439-106E7	77.86	57.17	10.89	9.98	1.27	1.82	2.18	2.54
prostate, adult, pool1	10022-101D4	114.00	92.60	9.61	11.79	4.90	2.72	2.09	1.81
putamen, adult, donor10196	10176-103C5	153.44	67.51	17.47	9.21	2.36	1.42	0.71	0.94
putamen, adult, donor10252	10152-102I8	74.51	94.11	11.76	11.76	5.88	1.96	3.92	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	48.08	19.67	4.37	9.84	0.00	1.09	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	100.75	35.52	17.88	10.15	1.45	0.00	0.24	0.72
putamen, newborn, donor10223	10365-105F5	44.98	59.97	3.75	2.25	0.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	58.77	35.79	6.98	6.11	4.95	2.62	2.62	0.58
rectum, fetal, donor1	10067-101I4	68.16	83.46	6.95	8.35	2.78	2.78	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	31.59	19.50	6.36	6.78	0.85	1.70	1.91	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	30.24	30.24	7.04	9.11	0.83	0.00	0.83	0.83
retina, adult, pool1	10030-101E3	73.16	57.45	7.75	7.55	3.48	2.58	2.19	0.40
retinoblastoma cell line:Y79	10475-106I7	47.54	28.32	6.75	8.05	0.78	1.30	0.78	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	31.84	21.15	4.67	3.69	0.86	0.37	0.74	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	80.70	32.90	12.65	17.15	4.78	2.53	1.12	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	31.07	27.28	4.55	0.76	2.27	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	21.37	28.00	2.43	1.46	1.29	0.00	0.49	0.32
salivary acinar cells, donor2	11772-123I8	23.96	30.02	3.17	1.51	0.28	0.83	0.69	0.14
salivary acinar cells, donor3	11773-123I9	41.05	64.22	3.97	1.99	2.65	1.99	0.66	0.66
salivary gland, adult, pool1	10093-102C3	191.60	52.05	13.15	12.58	4.58	1.72	2.86	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.17	35.83	4.55	3.46	0.17	0.34	0.42	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	27.04	33.27	3.29	2.12	0.12	0.24	0.24	0.47
seminal vesicle, adult	10201-103F3	69.31	67.19	6.88	5.82	3.17	0.00	1.06	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	30.85	52.47	3.89	2.43	6.56	5.10	1.21	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.85	21.14	1.76	1.51	0.50	0.75	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	41.14	40.14	8.03	2.01	3.01	2.01	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	27.00	42.98	3.09	2.42	1.34	0.27	0.67	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	45.98	21.11	7.63	6.63	2.54	1.55	2.32	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	48.90	31.87	4.64	4.13	0.65	0.26	1.42	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	65.97	122.71	14.19	37.59	12.77	4.97	9.22	2.13
skeletal muscle, adult, pool1	10023-101D5	211.69	147.16	14.15	20.87	4.80	2.28	4.92	2.76
skeletal muscle, fetal, donor1	10066-101I3	17.09	25.13	1.01	3.02	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	88.21	61.07	20.36	13.57	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	55.55	62.49	6.94	3.16	2.52	1.26	2.52	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	50.36	20.68	8.34	8.34	1.00	2.67	2.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	102.13	97.08	10.40	10.40	7.25	5.99	2.21	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	16.77	34.50	7.52	6.75	0.39	0.58	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	88.51	58.51	10.71	16.65	3.46	4.94	4.29	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	40.21	42.63	5.47	8.04	0.64	0.64	1.13	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	126.61	76.27	11.55	9.81	4.36	2.83	1.74	1.96
small intestine, adult, pool1	10024-101D6	132.46	76.56	10.15	8.72	3.11	1.55	1.79	1.67
small intestine, fetal, donor1	10064-101I1	62.90	51.84	8.85	4.91	2.21	1.97	0.98	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	45.65	34.36	3.59	7.18	6.15	1.03	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	222.79	194.88	14.47	15.51	4.65	3.10	2.33	4.39
somatostatinoma cell line:QGP-1	10781-110G7	82.01	53.07	7.24	5.63	2.68	1.61	2.41	0.54
spinal cord - adult, donor10196	10181-103D1	47.49	72.72	7.34	6.88	1.38	1.38	1.15	0.23
spinal cord, adult, donor10252	10159-103A6	99.75	96.60	11.83	6.31	3.55	0.79	1.58	0.39
spinal cord, adult, donor10258	10369-105F9	53.27	36.67	6.23	13.84	3.46	0.69	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	77.45	73.79	12.20	6.71	3.66	2.44	2.44	0.61
spinal cord, newborn, donor10223	10359-105E8	37.66	60.16	6.89	5.97	1.38	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	44.66	18.37	6.57	3.58	0.75	0.30	0.45	0.60
spleen, adult, pool1	10025-101D7	65.20	62.78	5.29	5.07	5.62	1.98	1.98	0.66
spleen, fetal, pool1	10044-101F8	65.79	56.89	5.09	3.58	5.16	3.18	1.19	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	39.75	19.87	6.83	9.42	3.31	2.48	2.48	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	75.00	61.33	4.37	4.94	2.28	1.14	2.66	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	63.95	57.66	6.29	5.94	1.40	1.40	2.80	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	23.46	42.22	4.30	6.65	3.52	0.78	1.95	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	132.82	54.14	23.19	19.70	1.13	1.69	2.59	1.91
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	36.43	42.78	8.47	9.32	3.81	4.24	0.42	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	16.08	31.31	3.81	3.38	0.42	0.85	0.42	0.42
stomach, fetal, donor1	10062-101H8	73.69	56.60	13.88	10.68	5.34	5.34	3.20	1.07
submaxillary gland, adult	10202-103F4	61.53	47.85	5.70	10.25	7.41	0.00	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	379.92	379.92	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	70.83	88.28	8.72	7.89	2.91	1.25	0.00	0.42
substantia nigra, adult, donor10258	10371-105G2	51.21	17.59	15.52	8.28	2.07	2.07	2.59	0.00
substantia nigra, newborn, donor10223	10358-105E7	21.20	45.93	2.12	6.36	1.41	0.00	3.53	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	32.33	16.97	3.44	4.36	0.69	0.92	1.15	0.92
temporal lobe, adult, pool1	10031-101E4	82.74	35.43	11.44	7.63	0.93	0.76	1.36	0.93
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	69.80	54.13	7.12	2.14	0.71	0.00	0.00	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	47.47	36.04	4.40	4.40	1.32	1.32	1.76	2.64
tenocyte, donor1	11763-123H8	33.51	34.21	3.49	2.79	1.75	1.05	0.35	1.40
tenocyte, donor2	11765-123I1	30.90	29.38	3.05	0.76	0.38	0.76	0.00	0.38
tenocyte, donor3	11768-123I4	25.95	28.17	0.74	1.48	0.37	0.37	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	121.35	50.31	13.77	10.03	2.89	1.87	1.53	2.89
teratocarcinoma cell line:NCR-G1	10798-110I6	37.00	18.19	6.01	5.09	3.85	3.70	2.47	0.77
teratocarcinoma cell line:PA-1	10807-111A6	55.17	17.05	8.06	7.13	6.66	4.65	2.32	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	54.84	34.53	3.05	2.54	1.90	1.40	1.02	2.03
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	63.91	33.66	3.03	8.32	3.40	2.27	1.51	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	93.14	65.55	8.07	7.42	3.82	4.04	4.69	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	57.98	28.34	6.19	3.91	1.30	2.61	1.95	0.98
testis, adult, pool1	10026-101D8	63.35	80.53	10.63	9.77	3.22	2.47	1.93	1.18
testis, adult, pool2	10096-102C6	32.48	37.44	10.37	11.28	3.16	1.80	1.80	0.45
thalamus - adult, donor10196	10168-103B6	61.82	58.51	9.94	9.94	2.21	2.21	1.10	2.21
thalamus, adult, donor10252	10154-103A1	77.05	92.68	7.03	7.35	1.88	1.25	1.41	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	44.65	30.79	9.24	7.70	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	29.48	16.14	6.75	2.14	0.99	0.33	0.66	0.49
thalamus, newborn, donor10223	10366-105F6	25.89	40.85	3.45	1.73	0.58	1.15	0.58	1.15
throat, adult	10209-103G2	76.90	89.88	8.74	8.24	4.99	2.00	2.00	1.50
throat, fetal, donor1	10061-101H7	79.22	69.17	9.14	7.01	2.13	0.91	2.13	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	22.46	29.01	2.19	2.19	0.20	0.40	0.40	0.79
thymus, adult, pool1	10027-101D9	120.49	38.47	10.24	14.61	4.18	4.87	8.25	1.49
thymus, fetal, pool1	10043-101F7	116.17	43.43	11.12	9.25	4.36	2.08	2.70	1.45
thyroid carcinoma cell line:KHM-5M	10776-110G2	19.94	32.58	2.93	2.39	3.19	1.73	0.80	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	40.09	22.91	5.45	4.61	1.54	2.24	1.96	0.84
thyroid, adult, pool1	10028-101E1	93.41	72.78	7.65	10.54	4.11	1.77	2.71	1.12
thyroid, fetal, donor1	10060-101H6	60.91	40.60	10.28	9.76	0.79	2.11	1.58	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	120.11	0.00	6.16	15.40	6.16	6.16	0.00
tongue, adult	10203-103F5	63.73	78.84	6.98	9.77	3.72	2.09	1.63	0.70
tongue, fetal, donor1	10059-101H5	128.47	119.41	12.61	8.67	3.55	1.58	1.18	3.55
tonsil, adult, pool1	10047-101G2	123.32	54.09	7.41	7.21	4.81	2.00	2.30	2.20
trachea, adult, pool1	10029-101E2	90.63	82.29	6.13	7.03	6.63	2.86	1.23	1.47
trachea, fetal, donor1	10058-101H4	57.70	98.10	8.08	5.39	1.92	0.77	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.13	20.55	3.90	1.42	0.35	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	53.80	30.90	12.16	9.22	3.44	2.03	3.14	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	40.27	54.21	7.21	5.80	0.78	0.63	2.19	1.41
tridermal teratoma cell line:HGRT	10694-109G1	43.76	34.25	11.42	5.71	15.22	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	21.92	18.62	2.88	2.71	0.42	0.34	0.34	0.08
umbilical cord, fetal, donor1	10057-101H3	47.99	58.42	14.61	4.17	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	105.28	99.31	5.46	9.73	7.17	3.07	1.54	1.37
uterus, fetal, donor1	10055-101H1	63.99	139.76	4.10	9.73	4.10	1.54	0.51	1.02
vagina, adult	10204-103F6	74.31	126.65	7.75	5.17	5.17	2.58	0.65	1.94
vein, adult	10191-103E2	30.69	35.95	4.82	4.82	3.29	1.10	0.88	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	19.49	9.88	3.20	1.07	1.07	0.27	1.07	0.53

Property "Nearest transcripts" (as page type) with input value "ENST00000455580.5:-26 ENST00000441461.5:54 AK303682:60 ENST00000427786.1:61 AK295957:61 AK316532:61 NM_206876.2:-62 ENST00000358506.6:63 ENST00000296122.10:129 BX647970:129 AK312329:139 ENST00000395366.3:145 NM_002709.3:145 BX647295:167 X80910:182 ENST00000464273.1:326 BC002697:359 BC012045:359 EU668339:359 AB464241:440 AM392772:440 CR542285:440 BT019744:440 KJ904529:440 CR542263:440" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.